10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED JANUARY 31, 2018

or

☐  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 1-16371

IDT CORPORATION

(Exact Name of Registrant as Specified in its Charter)

Delaware	22-3415036
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification Number)
520 Broad Street, Newark, New Jersey	07102
(Address of principal executive offices)	(Zip Code)

(973) 438-1000

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  ☒  No  ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  ☒   No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☒
Non-accelerated filer	☐  (Do not check if a smaller reporting company)	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.):  Yes  ☐  No  ☒

As of March 8, 2018, the registrant had the following shares outstanding:

Class A common stock, $.01 par value:	1,574,326 shares outstanding (excluding 1,698,000 treasury shares)
Class B common stock, $.01 par value:	23,279,953 shares outstanding (excluding 2,302,095 treasury shares)

IDT CORPORATION

TABLE OF CONTENTS

PART I.  FINANCIAL INFORMATION		1
Item 1.	Financial Statements (Unaudited)	1
	Consolidated Balance Sheets	1
	Consolidated Statements of Operations	2
	Consolidated Statements of Comprehensive Income (Loss)	3
	Consolidated Statements of Cash Flows	4
	Notes to Consolidated Financial Statements	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	19
Item 3.	Quantitative and Qualitative Disclosures About Market Risks	31
Item 4.	Controls and Procedures	31
PART II.  OTHER INFORMATION		32
Item 1.	Legal Proceedings	32
Item 1A.	Risk Factors	32
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	32
Item 3.	Defaults Upon Senior Securities	32
Item 4.	Mine Safety Disclosures	32
Item 5.	Other Information	32
Item 6.	Exhibits	33
SIGNATURES		34

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements (Unaudited)

IDT CORPORATION

CONSOLIDATED BALANCE SHEETS

	January 31, 2018			July 31, 2017
	(Unaudited)			(Note 1)
	(in thousands)
Assets
Current assets:
Cash and cash equivalents	$	54,055		$	90,344
Marketable securities		46,202			58,272
Trade accounts receivable, net of allowance for doubtful accounts of $2,642 at January 31, 2018 and $2,657 at July 31, 2017		71,652			64,979
Prepaid expenses		15,915			14,506
Other current assets		30,733			18,749
Assets held for sale		138,700			124,267
Total current assets		357,257			371,117
Property, plant and equipment, net		88,621			88,994
Goodwill		11,447			11,326
Investments		24,350			26,894
Deferred income tax assets, net		8,653			11,841
Other assets		8,616			3,657
Assets held for sale		5,285			5,134
Total assets	$	504,229		$	518,963
Liabilities and equity
Current liabilities:
Trade accounts payable	$	37,071		$	40,989
Accrued expenses		113,154			125,359
Deferred revenue		71,789			76,451
Other current liabilities		4,683			4,659
Liabilities held for sale		129,423			115,318
Total current liabilities		356,120			362,776
Other liabilities		1,107			1,080
Liabilities held for sale		642			550
Total liabilities		357,869			364,406
Commitments and contingencies
Equity:
IDT Corporation stockholders’ equity:
Preferred stock, $.01 par value; authorized shares—10,000; no shares issued		—			—
Class A common stock, $.01 par value; authorized shares—35,000; 3,272 shares issued and 1,574 shares outstanding at January 31, 2018 and July 31, 2017		33			33
Class B common stock, $.01 par value; authorized shares—200,000; 25,582 and 25,561 shares issued and 23,280 and 23,264 shares outstanding at January 31, 2018 and July 31, 2017, respectively		256			256
Additional paid-in capital		396,259			394,462
Treasury stock, at cost, consisting of 1,698 and 1,698 shares of Class A common stock and 2,302 and 2,297 shares of Class B common stock at January 31, 2018 and July 31, 2017, respectively		(83,365	)		(83,304	)
Accumulated other comprehensive loss		(2,531	)		(2,343	)
Accumulated deficit		(173,386	)		(163,370	)
Total IDT Corporation stockholders’ equity		137,266			145,734
Noncontrolling interests		9,094			8,823
Total equity		146,360			154,557
Total liabilities and equity	$	504,229		$	518,963

See accompanying notes to consolidated financial statements.

1

IDT CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)

	Three Months Ended January 31,						Six Months Ended January 31,
		2018		2017				2018		2017
	(in thousands, except per share data)
Revenues	$	395,883		$	367,556		$	789,438		$	736,707
Costs and expenses:
Direct cost of revenues (exclusive of depreciation and amortization)		337,229			310,913			673,738			623,941
Selling, general and administrative (i)		52,358			47,325			102,429			92,763
Depreciation and amortization		5,735			5,301			11,408			10,601
Severance		195			—			635			—
Total costs and expenses		395,517			363,539			788,210			727,305
Other operating expense		(846	)		(889	)		(1,625	)		(1,088	)
(Loss) income from operations		(480	)		3,128			(397	)		8,314
Interest income, net		286			309			648			609
Other income (expense), net		370			(419	)		(456	)		1,974
Income (loss) before income taxes		176			3,018			(205	)		10,897
Benefit from (provision for) income taxes		1,514			(1,761	)		99			12,655
Net income (loss)		1,690			1,257			(106	)		23,552
Net income attributable to noncontrolling interests		(174	)		(382	)		(470	)		(758	)
Net income (loss) attributable to IDT Corporation	$	1,516		$	875		$	(576	)	$	22,794
Earnings (loss) per share attributable to IDT Corporation common stockholders:
Basic	$	0.06		$	0.04		$	(0.02	)	$	1.00
Diluted	$	0.06		$	0.04		$	(0.02	)	$	0.99
Weighted-average number of shares used in calculation of earnings (loss) per share:
Basic		24,643			22,768			24,635			22,740
Diluted		24,724			22,963			24,635			22,931
Dividends declared per common share	$	0.19		$	0.19		$	0.38		$	0.38
(i) Stock-based compensation included in selling, general and administrative expenses	$	987		$	1,426		$	1,797		$	2,128

See accompanying notes to consolidated financial statements. 

2

IDT CORPORATION

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)

	Three Months Ended January 31,						Six Months Ended January 31,
	2018			2017			2018			2017
	(in thousands)
Net income (loss)	$	1,690		$	1,257		$	(106	)	$	23,552
Other comprehensive income (loss):
Change in unrealized loss on available-for-sale securities		(120	)		(40	)		(150	)		(63	)
Foreign currency translation adjustments		330			459			(38	)		(2,403	)
Other comprehensive income (loss)		210			419			(188	)		(2,466	)
Comprehensive income (loss)		1,900			1,676			(294	)		21,086
Comprehensive income attributable to noncontrolling interests		(174	)		(382	)		(470	)		(758	)
Comprehensive income (loss) attributable to IDT Corporation	$	1,726		$	1,294		$	(764	)	$	20,328

See accompanying notes to consolidated financial statements.

3

IDT CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

	Six Months Ended January 31,
	2018			2017
	(in thousands)
Operating activities
Net (loss) income	$	(106	)	$	23,552
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization		11,408			10,601
Deferred income taxes		3,212			(12,868	)
Provision for doubtful accounts receivable		696			126
Realized loss (gain) on marketable securities		9			(305	)
Interest in the equity of investments		(77	)		(295	)
Stock-based compensation		1,797			2,128
Change in assets and liabilities:
Restricted cash and cash equivalents		(3,663	)		4,098
Trade accounts receivable		(4,568	)		(8,189	)
Prepaid expenses, other current assets and other assets		(15,109	)		(1,432	)
Trade accounts payable, accrued expenses, other current liabilities and other liabilities		(20,344	)		(15,010	)
Customer deposits		4,481			(1,177	)
Deferred revenue		(4,710	)		(2,043	)
Net cash used in operating activities		(26,974	)		(814	)
Investing activities
Capital expenditures		(10,931	)		(10,543	)
Proceeds from sale of interest in Straight Path IP Group Holding, Inc.		6,000			—
Purchase of IP Interest from Straight Path Communications Inc.		(6,000	)		—
Payment for acquisition, net of cash acquired		—			(1,827	)
Cash used for investments		—			(8,304	)
Purchases of marketable securities		(19,797	)		(17,209	)
Proceeds from maturities and sales of marketable securities		31,610			16,848
Net cash provided by (used in) investing activities		882			(21,035	)
Financing activities
Dividends paid		(9,440	)		(8,765	)
Distributions to noncontrolling interests		(717	)		(817	)
Proceeds from borrowings under revolving credit facility		19,080			—
Repayments of borrowings under revolving credit facility		(19,080	)		—
Proceeds from exercise of stock options		—			835
Proceeds from sale of member interests in CS Pharma Holdings, LLC.		—			1,250
Repurchases of Class B common stock		(61	)		(1,838	)
Net cash used in financing activities		(10,218	)		(9,335	)
Effect of exchange rate changes on cash and cash equivalents		592			(829	)
Net decrease in cash and cash equivalents		(35,718	)		(32,013	)
Cash and cash equivalents at beginning of period, including $5,716 held for sale at July 31, 2017		96,060			109,537
Cash and cash equivalents at end of period, including $6,287 held for sale at January 31, 2018	$	60,342		$	77,524
Supplemental schedule of non-cash investing and financing activities
Reclassification of liability for member interests in CS Pharma Holdings, LLC	$	—		$	8,750

See accompanying notes to consolidated financial statements.

4

IDT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

Note 1—Basis of Presentation

The accompanying unaudited consolidated financial statements of IDT Corporation and its subsidiaries (the “Company” or “IDT”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six months ended January 31, 2018 are not necessarily indicative of the results that may be expected for the fiscal year ending July 31, 2018. The balance sheet at July 31, 2017 has been derived from the Company’s audited financial statements at that date but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. For further information, please refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended July 31, 2017, as filed with the U.S. Securities and Exchange Commission (“SEC”).

The Company’s fiscal year ends on July 31 of each calendar year. Each reference below to a fiscal year refers to the fiscal year ending in the calendar year indicated (e.g., fiscal 2018 refers to the fiscal year ending July 31, 2018).

Note 2— IDT Financial Services Holding Limited Assets and Liabilities Held for Sale

On June 22, 2017, the Company’s wholly-owned subsidiary IDT Telecom, Inc. (“IDT Telecom”) entered into a Share Purchase Agreement with JAR Fintech Limited (“JAR Fintech”) and JAR Capital Limited to sell the capital stock of IDT Financial Services Holding Limited, a company incorporated under the laws of Gibraltar and a wholly-owned subsidiary of IDT Telecom (“IDTFS Holding”), to JAR Fintech. IDTFS Holding is the sole shareholder of IDT Financial Services Limited (“IDTFS”), a Gibraltar-based bank and e-money issuer, providing prepaid card solutions across the European Economic Area. The Share Purchase Agreement provides for an aggregate purchase price for the outstanding equity interests of IDTFS Holding of approximately $4.1 million plus an amount equal to the value of IDTFS’ net assets, to be paid at closing, subject to adjustments relating to customer assets of IDTFS. The net asset value of IDTFS was $14.5 million at January 31, 2018. A portion of the purchase price will be placed in escrow at closing and released to IDT Telecom once all of the conditions have been met under the Share Purchase Agreement. The sale is expected to close in the second quarter of calendar 2018, subject to regulatory approval and other customary conditions set forth in the Share Purchase Agreement. The remaining closing conditions are outside of the Company’s control and there can be no assurance that the sale will be completed.

The pending disposition of IDTFS Holding did not meet the criteria to be reported as a discontinued operation and accordingly, its results of operations and cash flows have not been reclassified. The IDTFS Holding assets and liabilities held for sale included the following:

	January 31, 2018		July 31, 2017
	(in thousands)
Current assets held for sale:
Cash and cash equivalents	$	6,287	$	5,716
Restricted cash and cash equivalents		128,153		115,609
Trade accounts receivable, net of allowance for doubtful accounts of $3,239 and $2,550 at January 31, 2018 and July 31, 2017, respectively		2,919		1,844
Prepaid expenses		854		758
Other current assets		487		340
Total current assets held for sale	$	138,700	$	124,267
Noncurrent assets held for sale:
Property, plant and equipment, net	$	19	$	24
Other intangibles, net		164		165
Other assets		5,102		4,945
Total noncurrent assets held for sale	$	5,285	$	5,134
Current liabilities held for sale:
Trade accounts payable	$	2,007	$	372
Accrued expenses		252		226
Customer deposits		127,107		114,689
Other current liabilities		57		31
Total current liabilities held for sale	$	129,423	$	115,318
Noncurrent liabilities held for sale:
Other liabilities	$	642	$	550
Total noncurrent liabilities held for sale	$	642	$	550

5

IDTFS Holding is included in the Telecom Platform Services segment. IDTFS Holding’s (loss) income before income taxes and (loss) income before income taxes attributable to the Company, which is included in the accompanying consolidated statements of operations, were as follows:

	Three Months Ended January 31,						Six Months Ended January 31,
	2018			2017			2018			2017
	(in thousands)
(Loss) income before income taxes	$	(559	)	$	(421	)	$	(1,009	)	$	174
(Loss) income before income taxes attributable to IDT Corporation	$	(559	)	$	(421	)	$	(1,009	)	$	174

Note 3—Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc.

On or about March 26, 2018, the Company expects to spin-off its subsidiary, Rafael Holdings, Inc. (“RHI”), to the Company’s stockholders, so that RHI will be a separate publicly traded company. Approval of the spin-off by the Company’s stockholders is not required. The Company’s Board of Directors believes that the spin-off will allow RHI to better focus on its strategic mission and that its potential can be better realized as an independent entity. The spin-off of RHI will occur by way of a pro rata distribution of RHI’s capital stock to the Company’s stockholders. On the distribution date, each of the Company’s stockholders as of the record date for the distribution of March 13, 2018 will receive one share of RHI Class A common stock for every two shares of the Company’s Class A common stock and one share of RHI Class B common stock for every two shares of the Company’s Class B common stock. Completion of the RHI spin-off is subject to receipt of a favorable opinion as to the spin-off’s tax-free status.

RHI owns the commercial real estate assets held by the Company and interests in two clinical stage pharmaceutical companies. The commercial real estate holdings consist of the Company’s headquarters building and its associated public garage in Newark, New Jersey, an office/data center building in Piscataway, New Jersey and a portion of a building in Israel that hosts offices for the Company and certain affiliates. The pharmaceutical holdings include debt interests and warrants in Rafael Pharmaceuticals, Inc. (“Rafael Pharma”), which is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells, and a majority equity interest in Lipomedix Pharmaceuticals Ltd., a pharmaceutical development company based in Israel. In addition, prior to the spin-off, the Company intends to transfer assets to RHI such that, at the time of the spin-off, RHI will have approximately $44 million in cash, cash equivalents, and marketable securities, plus $6 million in hedge fund and other investments.

RHI’s interests in Rafael Pharma, which are held through a 90%-owned non-operating subsidiary, IDT-Rafael Holdings, LLC (“IDT-Rafael Holdings”), include convertible notes issued by Rafael Pharma, and a warrant held by the Company and certain minority holders to purchase up to a majority equity stake in Rafael Pharma at the Company’s discretion in accordance with the terms of the convertible note and the warrant. The remaining 10% of IDT-Rafael Holdings is held by Howard S. Jonas, the Company’s Chairman of the Board, and Chairman of the Board of Rafael Pharma.

IDT-Rafael Holdings had the contractual right to receive additional shares of Rafael Pharma representing 10% of the outstanding capital stock of Rafael Pharma that will be issued upon the occurrence of any of the following: (i) Food and Drug Administration approval of a Rafael Pharma drug application, (ii) an initial public offering of Rafael Pharma at a valuation of over $500 million, or (iii) a sale of Rafael Pharma above certain valuations. Currently, none of the conditions have been satisfied and the right remains contingent. On September 14, 2017, IDT-Rafael Holdings distributed this right to its members on a pro rata basis such that the Company received the right to 9% of the outstanding capital stock of Rafael Pharma and Howard Jonas received the right to 1% of the outstanding capital stock of Rafael Pharma. In addition, as compensation for assuming the role of Chairman of the Board of Rafael Pharma, and to create additional incentive to contribute to the success of Rafael Pharma, on September 19, 2017, the Company transferred its right to receive 9% of the outstanding capital stock of Rafael Pharma to Mr. Jonas. The right is further transferable at the discretion of Mr. Jonas.

Howard Jonas and his wife Deborah Jonas jointly own $525,000 of Series C Convertible Notes of Rafael Pharma, and The Howard S. and Deborah Jonas Foundation own an additional $525,000 of Series C Convertible Notes of Rafael Pharma. 

IDT-Rafael Holdings’ controlled 50%-owned subsidiary, CS Pharma Holdings, LLC (“CS Pharma”), holds Rafael Pharma’s Series D convertible promissory note with a principal amount of $10 million (the “Series D Note”). The Series D Note earns interest at 3.5% per annum, with principal and accrued interest due and payable on September 16, 2018. The Series D Note is convertible at the holder’s option into shares of Rafael Pharma’s Series D Preferred Stock. The Series D Note also includes a mandatory conversion into Rafael Pharma common stock upon a qualified initial public offering, and conversion at the holder’s option upon an unqualified financing event. In all cases, the Series D Note conversion price is based on the applicable financing purchase price.

IDT-Rafael Holdings and CS Pharma hold warrants to purchase shares of capital stock of Rafael Pharma representing in the aggregate up to 56% of the then issued and outstanding capital stock of Rafael Pharma, on an as-converted and fully diluted basis. The right to exercise warrants as to the first $10 million thereof is held by CS Pharma. The exercise price of the warrant is the lower of 70% of the price sold in an equity financing, or $1.25 per share, subject to certain adjustments. The minimum initial and subsequent exercises of the warrant shall be for such number of shares that will result in at least $5 million of gross proceeds to Rafael Pharma, or such lesser amount as represents 5% of the outstanding capital stock of Rafael Pharma, or such lesser amount as may then remain unexercised. The warrant will expire upon the earlier of December 31, 2020 or a qualified initial public offering or liquidation event. 

6

The Company’s investment in Rafael Pharma, which was included in “Investments” in the accompanying consolidated balance sheets, consists of the following:

	January 31, 2018		July 31, 2017
	(in thousands)
Series D Note (at fair value)	$	6,300	$	6,300
Warrants (at cost)		5,400		5,400
Right to receive additional shares (at cost)		—		400
Total investment in Rafael Pharma	$	11,700	$	12,100

Rafael Pharma is a variable interest entity, however, the Company has determined that it is not the primary beneficiary as the Company does not have the power to direct the activities of Rafael Pharma that most significantly impact Rafael Pharma’s economic performance. At January 31, 2018, the Company’s maximum exposure to loss as a result of its involvement with Rafael Pharma was its $11.7 million investment, since there were no other arrangements, events or circumstances that could expose the Company to additional loss.

Note 4—Marketable Securities

The following is a summary of marketable securities:

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
	(in thousands)
Available-for-sale securities:
January 31, 2018:
Certificates of deposit*	$	24,441	$	2	$	(1	)	$	24,442
Federal Government Sponsored Enterprise notes		3,216		—		(26	)		3,190
International agency notes		399		—		(9	)		390
Mutual funds		5,425		40		—			5,465
Corporate bonds		3,332		—		(39	)		3,293
Equity		79		—		(3	)		76
U.S. Treasury notes		5,397		—		(76	)		5,321
Municipal bonds		4,029		—		(4	)		4,025
Total	$	46,318	$	42	$	(158	)	$	46,202
July 31, 2017:
Certificates of deposit*	$	29,011	$	1	$	(7	)	$	29,005
Federal Government Sponsored Enterprise notes		3,992		—		(14	)		3,978
International agency notes		291		—		—			291
Mutual funds		5,353		77		—			5,430
Corporate bonds		4,643		—		—			4,643
Equity		74		—		(26	)		48
U.S. Treasury notes		6,673		—		—			6,673
Municipal bonds		8,201		4		(1	)		8,204
Total	$	58,238	$	82	$	(48	)	$	58,272

* Each of the Company’s certificates of deposit has a CUSIP, was purchased in the secondary market through a broker, and may be sold in the secondary market.

7

At January 31, 2018 and July 31, 2017, the Company owned 24,923 and 23,227 shares, respectively, of Zedge, Inc. Class B common stock that had a fair value of $76,000 and $48,000, respectively.

Proceeds from maturities and sales of available-for-sale securities were $12.1 million and $10.8 million in the three months ended January 31, 2018 and 2017, respectively, and $31.6 million and $16.8 million in the six months ended January 31, 2018 and 2017, respectively. The gross realized losses that were included in earnings as a result of sales were $16,000 and $9,000 in the three and six months ended January 31, 2018, respectively. The gross realized gains that were included in earnings as a result of sales were $0.3 million in the three and six months ended January 31, 2017. The Company uses the specific identification method in computing the gross realized gains and gross realized losses on the sales of marketable securities.

The contractual maturities of the Company’s available-for-sale debt securities at January 31, 2018 were as follows:

	Fair Value
	(in thousands)
Within one year	$	25,771
After one year through five years		14,890
After five years through ten years		—
After ten years		—
Total	$	40,661

The following available-for-sale securities were in an unrealized loss position for which other-than-temporary impairments have not been recognized:

	Unrealized Losses		Fair Value
	(in thousands)
January 31, 2018:
Certificates of deposit	$	1	$	5,340
Federal Government Sponsored Enterprise notes		26		3,190
International agency notes		9		390
Corporate bonds		39		3,293
Equity		3		76
U.S. Treasury notes		76		5,321
Municipal bonds		4		3,067
Total	$	158	$	20,677
July 31, 2017:
Certificates of deposit	$	7	$	12,155
Federal Government Sponsored Enterprise notes		14		3,529
Equity		26		48
Municipal bonds		1		3,349
Total	$	48	$	19,081

8

At July 31, 2017, there were no securities in a continuous unrealized loss position for 12 months or longer. At January 31, 2018, the following available-for-sale securities included in the table above were in a continuous unrealized loss position for 12 months or longer:

	Unrealized Losses		Fair Value
	(in thousands)
Federal Government Sponsored Enterprise notes	$	13	$	1,810
Municipal bonds		1		348
Total	$	14	$	2,158

At January 31, 2018, the Company did not intend to sell the securities that were in a continuous unrealized loss position for 12 months or longer, and it is not more likely than not that the Company will be required to sell the securities before recovery of their amortized cost bases, which may be at maturity.

Note 5—Fair Value Measurements

The following tables present the balance of assets measured at fair value on a recurring basis:

	Level 1 (1)		Level 2 (2)		Level 3 (3)		Total
	(in thousands)
January 31, 2018
Available-for-sale securities:
Marketable securities	$	10,862	$	35,340	$	—	$	46,202
Rafael Pharma Series D Note		—		—		6,300		6,300
Total	$	10,862	$	35,340	$	6,300	$	52,502
July 31, 2017
Available-for-sale securities:
Marketable securities	$	12,151	$	46,121	$	—	$	58,272
Rafael Pharma Series D Note		—		—		6,300		6,300
Total	$	12,151	$	46,121	$	6,300	$	64,572

(1) – quoted prices in active markets for identical assets or liabilities

(2) – observable inputs other than quoted prices in active markets for identical assets and liabilities

(3) – no observable pricing inputs in the market

At January 31, 2018 and July 31, 2017, the Company did not have any liabilities measured at fair value on a recurring basis.

At January 31, 2018 and July 31, 2017, the fair value of the Rafael Pharma Series D Note, which was classified as Level 3, was estimated based on a valuation of Rafael Pharma and other factors that could not be corroborated by the market.

The following table summarizes the change in the balance of the Company’s assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3). There were no liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) in the three and six months ended January 31, 2018 and 2017.

	Three Months Ended January 31,				Six Months Ended January 31,
	2018		2017		2018		2017
	(in thousands)
Balance, beginning of period	$	6,300	$	4,200	$	6,300	$	2,000
Purchases		—		—		—		2,200
Balance, end of period	$	6,300	$	4,200	$	6,300	$	4,200
Change in unrealized gains or losses for the period included in earnings for assets held at the end of the period	$	—	$	—	$	—	$	—

9

At January 31, 2018 and July 31, 2017, the Company had $8.8 million and $8.6 million, respectively, in investments in hedge funds, which were included in “Investments” in the accompanying consolidated balance sheets. The Company’s investments in hedge funds are accounted for using the equity method or the cost method, therefore investments in hedge funds are not measured at fair value.

Fair Value of Other Financial Instruments

The estimated fair value of the Company’s other financial instruments was determined using available market information or other appropriate valuation methodologies. However, considerable judgment is required in interpreting these data to develop estimates of fair value. Consequently, the estimates are not necessarily indicative of the amounts that could be realized or would be paid in a current market exchange.

Cash and cash equivalents, restricted cash and cash equivalents, other current assets, customer deposits and other current liabilities. At January 31, 2018 and July 31, 2017, the carrying amount of these assets and liabilities approximated fair value because of the short period of time to maturity. The fair value estimates for cash, cash equivalents and restricted cash and cash equivalents were classified as Level 1 and other current assets, customer deposits and other current liabilities were classified as Level 2 of the fair value hierarchy.

Other assets and other liabilities. At January 31, 2018 and July 31, 2017, the carrying amount of these assets and liabilities approximated fair value. The fair values were estimated based on the Company’s assumptions, which were classified as Level 3 of the fair value hierarchy.

The Company’s investments at January 31, 2018 and July 31, 2017 included investments in the equity of certain privately held entities and other investments that are accounted for at cost. It is not practicable to estimate the fair value of these investments because of the lack of a quoted market price for the shares of these entities, and the inability to estimate their fair value without incurring excessive cost. The carrying value of these investments was $10.4 million and $10.8 million at January 31, 2018 and July 31, 2017, respectively, which the Company believes was not impaired.

Note 6— Equity

Changes in the components of equity were as follows:

	Six Months Ended January 31, 2018
	Attributable to IDT Corporation			Noncontrolling Interests			Total
	(in thousands)
Balance, July 31, 2017	$	145,734		$	8,823		$	154,557
Dividends declared ($0.38 per share)		(9,440	)		—			(9,440	)
Restricted Class B common stock purchased from employees		(61	)		—			(61	)
Transfer of right to receive equity to Howard S. Jonas		—			(40	)		(40	)
Consolidation of Lipomedix Pharmaceuticals Ltd.		—			558			558
Distributions to noncontrolling interests		—			(717	)		(717	)
Stock-based compensation		1,797			—			1,797
Comprehensive income:
Net loss		(576	)		470			(106	)
Other comprehensive loss		(188	)		—			(188	)
Comprehensive income		(764	)		470			(294	)
Balance, January 31, 2018	$	137,266		$	9,094		$	146,360

Dividend Payments

In the six months ended January 31, 2018, the Company paid cash dividends of $0.38 per share on its Class A common stock and Class B common stock, or $9.4 million in total. In the six months ended October 31, 2016, the Company paid cash dividends of $0.38 per share on its Class A common stock and Class B common stock, or $8.8 million in total.

On March 5, 2018, the Company’s Board of Directors declared a dividend of $0.09 per share for the second quarter of fiscal 2018 to holders of the Company’s Class A common stock and Class B common stock. The dividend will be paid on or about March 23, 2018 to stockholders of record as of the close of business on March 19, 2018.

10

Stock Repurchases

The Company has a stock repurchase program for the repurchase of up to an aggregate of 8.0 million shares of the Company’s Class B common stock. There were no repurchases under the program in the six months ended January 31, 2018 or 2017. At January 31, 2018, 8.0 million shares remained available for repurchase under the stock repurchase program.

In the six months ended January 31, 2018 and 2017, the Company paid $0.1 million and $1.8 million, respectively, to repurchase 5,170 shares and 94,338 shares, respectively, of Class B common stock that were tendered by employees of the Company to satisfy the employees’ tax withholding obligations in connection with the lapsing of restrictions on awards of restricted stock. Such shares were repurchased by the Company based on their fair market value on the trading day immediately prior to the vesting date.

2015 Stock Option and Incentive Plan

On December 14, 2017, the Company’s stockholders approved an amendment to the Company’s 2015 Stock Option and Incentive Plan to increase the number of shares of the Company’s Class B common stock available for the grant of awards thereunder by an additional 0.3 million shares.

In the six months ended January 31, 2017, the Company received proceeds from the exercise of its stock options of $0.8 million. There were no stock option exercises in the six months ended January 31, 2018. In the six months ended January 31, 2017, the Company issued 73,471 shares of its Class B common stock for the stock option exercises.

Note 7— Earnings (Loss) Per Share

Basic earnings per share is computed by dividing net income attributable to all classes of common stockholders of the Company by the weighted average number of shares of all classes of common stock outstanding during the applicable period. Diluted earnings per share is computed in the same manner as basic earnings per share, except that the number of shares is increased to include restricted stock still subject to risk of forfeiture and to assume exercise of potentially dilutive stock options using the treasury stock method, unless the effect of such increase is anti-dilutive.

The weighted-average number of shares used in the calculation of basic and diluted earnings (loss) per share attributable to the Company’s common stockholders consists of the following:

	Three Months Ended January 31,				Six Months Ended January 31,
	2018		2017		2018		2017
	(in thousands)
Basic weighted-average number of shares		24,643		22,768		24,635		22,740
Effect of dilutive securities:
Stock options		10		77		—		58
Non-vested restricted Class B common stock		71		118		—		133
Diluted weighted-average number of shares		24,724		22,963		24,635		22,931

The following shares were excluded from the diluted earnings per share computation:

	Three Months Ended January 31,				Six Months Ended January 31,
	2018		2017		2018		2017
	(in thousands)
Stock options		1,160		3		1,273		18
Non-vested restricted Class B common stock		—		—		191		—
Shares excluded from the calculation of diluted earnings per share		1,160		3		1,464		18

In the three months ended January 31, 2018, and in the three and six months ended January 31, 2017, stock options with an exercise price that was greater than the average market price of the Company’s stock during the period were excluded from the diluted earnings per share computation.

In the six months ended January 31, 2018, the diluted loss per share computation equals basic loss per share because the Company had a net loss and the impact of the assumed exercise of stock options and the vesting of restricted stock would have been anti-dilutive.

11

Note 8—Revolving Credit Facility

The Company’s subsidiary, IDT Telecom, entered into a credit agreement, dated July 12, 2012, with TD Bank, N.A. for a line of credit facility for up to a maximum principal amount of $25.0 million. The credit agreement was amended as of January 31, 2018. IDT Telecom may use the proceeds to finance working capital requirements, acquisitions and for other general corporate purposes. The line of credit facility is secured by primarily all of IDT Telecom’s assets. The principal outstanding bears interest per annum, at the option of IDT Telecom, at either (a) the U.S. Prime Rate less 125 basis points, or (b) the LIBOR rate adjusted by the Regulation D maximum reserve requirement plus 125 basis points. Interest is payable monthly and all outstanding principal and any accrued and unpaid interest is due on the maturity date of January 31, 2020. At January 31, 2018 and July 31, 2017, there were no amounts outstanding under the facility. The Company intends to borrow under the facility from time to time. IDT Telecom pays a quarterly unused commitment fee of 0.325% per annum on the average daily balance of the unused portion of the $25.0 million commitment. IDT Telecom is required to comply with various affirmative and negative covenants as well as maintain certain financial targets and ratios during the term of the line of credit, including restrictions on dividend payments on IDT Telecom capital stock and restrictions on IDT Telecom’s aggregate loans and advances to affiliates or subsidiaries.

Note 9—Accumulated Other Comprehensive Loss

The accumulated balances for each classification of other comprehensive loss were as follows:

	Unrealized Gain (Loss) on Available-for-Sale Securities			Foreign Currency Translation			Accumulated Other Comprehensive Loss			Location of (Gain) Loss Recognized
	(in thousands)
Balance, July 31, 2017	$	2,134		$	(4,477	)	$	(2,343	)
Other comprehensive loss attributable to IDT Corporation before reclassifications		(159	)		(38	)		(197	)
Less: reclassification for loss included in net loss		9			—			9		Other income (expense), net
Net other comprehensive loss attributable to IDT Corporation		(150	)		(38	)		(188	)
Balance, January 31, 2018	$	1,984		$	(4,515	)	$	(2,531	)

At both January 31, 2018 and July 31, 2017, unrealized gain on available-for-sale securities included unrealized gain of $2.1 million on the Rafael Pharma Series D Note.

Note 10—Business Segment Information

The Company has two reportable business segments, Telecom Platform Services and net2phone-Unified Communications as a Service (“net2phone-UCaaS”) (formerly known as UCaaS). The Company’s reportable segments are distinguished by types of service, customers and methods used to provide their services. The operating results of these business segments are regularly reviewed by the Company’s chief operating decision maker.

Telecom Platform Services and net2phone-UCaaS comprise the IDT Telecom division. The Telecom Platform Services segment provides retail telecommunications and payment offerings as well as wholesale international long distance traffic termination. The net2phone-UCaaS segment is comprised of (1) cable telephony, (2) cloud-based private branch exchange, or PBX, services offered to enterprise customers exclusively through value-added resellers, service providers, telecom agents and managed service providers, (3) Session Initiation Protocol, or SIP, trunking, which supports inbound and outbound domestic and international calling from an IP PBX, and (4) PicuP, a highly-automated business phone service that answers, routes and manages voice calls.

Beginning in the first quarter of fiscal 2018, the Telecom Platform Services segment includes Consumer Phone Services, which was previously reported as a separate segment. Consumer Phone Services provides consumer local and long distance services in certain U.S. states. Comparative results have been reclassified and restated as if Consumer Phone Services was included in Telecom Platform Services in all periods presented.

Operating segments not reportable individually are included in All Other. All Other includes the Company’s real estate holdings and other smaller businesses. Corporate costs include certain services, such as compensation, consulting fees, treasury and accounts payable, tax and accounting services, human resources and payroll, corporate purchasing, corporate governance including Board of Directors’ fees, internal and external audit, investor relations, corporate insurance, corporate legal, business development, and other corporate-related general and administrative expenses including, among others, facilities costs, charitable contributions and travel, as well as depreciation expense on corporate assets. Corporate does not generate any revenues, nor does it incur any direct cost of revenues.

12

The accounting policies of the segments are the same as the accounting policies of the Company as a whole. The Company evaluates the performance of its business segments based primarily on income (loss) from operations. IDT Telecom depreciation and amortization are allocated to Telecom Platform Services and net2phone-UCaaS because the related assets are not tracked separately by segment. There are no other significant asymmetrical allocations to segments.

Operating results for the business segments of the Company are as follows:

(in thousands)	Telecom Platform Services		net2phone-UCaaS			All Other			Corporate			Total
Three Months Ended January 31, 2018
Revenues	$	387,065	$	8,299		$	519		$	—		$	395,883
Income (loss) from operations		4,589		(790	)		(1,019	)		(3,260	)		(480	)
Severance		195		—			—			—			195
Other operating expense		—		—			—			(846	)		(846	)
Three Months Ended January 31, 2017
Revenues	$	359,924	$	7,142		$	490		$	—		$	367,556
Income (loss) from operations		7,187		(464	)		82			(3,677	)		3,128
Other operating expense		—		—			—			(889	)		(889	)
Six Months Ended January 31, 2018
Revenues	$	772,129	$	16,087		$	1,222		$	—		$	789,438
Income (loss) from operations		9,150		(1,464	)		(1,650	)		(6,433	)		(397	)
Severance		605		—			—			30			635
Other operating expense		—		—			—			(1,625	)		(1,625	)
Six Months Ended January 31, 2017
Revenues	$	721,435	$	14,278		$	994		$	—		$	736,707
Income (loss) from operations		13,732		(639	)		172			(4,951	)		8,314
Other operating expense		—		—			—			(1,088	)		(1,088	)

Note 11—Commitments and Contingencies

Legal Proceedings

On July 31, 2013, the Company completed a pro rata distribution of the common stock of the Company’s subsidiary Straight Path Communications Inc. (“Straight Path”) to the Company’s stockholders of record as of the close of business on July 25, 2013 (the “Straight Path Spin-Off”). On July 5, 2017, plaintiff JDS1, LLC, on behalf of itself and all other similarly situated stockholders of Straight Path, and derivatively on behalf of Straight Path as nominal defendant, filed a putative class action and derivative complaint in the Court of Chancery of the State of Delaware against the Company, The Patrick Henry Trust (a trust formed by Howard S. Jonas that held record and beneficial ownership of certain shares of Straight Path he formerly held), Howard S. Jonas, and each of Straight Path’s directors. The complaint alleges that the Company aided and abetted Straight Path Chairman of the Board and Chief Executive Officer Davidi Jonas, and Howard S. Jonas in his capacity as controlling stockholder of Straight Path, in breaching their fiduciary duties to Straight Path in connection with the settlement of claims between Straight Path and the Company related to potential indemnification claims concerning Straight Path’s obligations under the Consent Decree it entered into with the Federal Communications Commission (“FCC”), as well as the proposed sale of Straight Path’s subsidiary Straight Path IP Group, Inc. (“SPIP”) to the Company in connection with that settlement. That action was consolidated with a similar action that was initiated by The Arbitrage Fund. The Plaintiffs are seeking, among other things, (i) a declaration that the action may be maintained as a class action or in the alternative, that demand on the Straight Path Board is excused; (ii) that the term sheet is invalid; (iii) awarding damages for the unfair price stockholders are receiving in the merger between Straight Path and Verizon Communications Inc. for their shares of Straight Path’s Class B common stock; and (iv) ordering Howard S. Jonas, Davidi Jonas, and the Company to disgorge any profits for the benefit of the class Plaintiffs. On August 28, 2017, the Plaintiffs filed an amended complaint. On September 24, 2017, the Company filed a motion to dismiss the amended complaint. The Company intends to vigorously defend the action. On November 20, 2017, the Delaware Chancery Court issued an order staying the case pending the closing of the transaction between Verizon and Straight Path on the grounds that the claims are not ripe. That transaction closed on February 28, 2018 and the Court was so notified. In the three and six months ended January 31, 2018, the Company incurred legal fees of $0.2 million and $1.0 million, respectively, related to this putative class action, which is included in “Other operating expense” in the accompanying consolidated statement of operations.

13

On May 5, 2004, the Company filed a complaint in the Supreme Court of the State of New York, County of New York, seeking injunctive relief and damages against Tyco Group, S.A.R.L., Tyco Telecommunications (US) Inc. (f/k/a TyCom (US) Inc.), Tyco International, Ltd., Tyco International (US) Inc., and TyCom Ltd. (collectively “Tyco”). The Company alleged that Tyco breached a settlement agreement that it had entered into with the Company to resolve certain disputes and civil actions among the parties. The Company alleged that Tyco did not provide the Company, as required under the settlement agreement, free of charge and for the Company’s exclusive use, a 15-year indefeasible right to use four Wavelengths in Ring Configuration (as defined in the settlement agreement) on a global undersea fiber optic network that Tyco was deploying at that time. After extensive proceedings, including several decisions and appeals, the New York Court of Appeals affirmed a lower court decision to dismiss the Company’s claim and denied the Company’s motion for re-argument of that decision. On June 23, 2015, the Company filed a new summons and complaint against Tyco in the Supreme Court of the State of New York, County of New York alleging that Tyco breached the settlement agreement. In September 2015, Tyco filed a motion to dismiss the complaint, which the Company opposed. Oral argument was held on March 9, 2016. On October 17, 2016, the judge granted Tyco’s motion and dismissed the complaint. In August 2017, the Company filed an appeal, which Tyco opposed. On November 22, 2017, oral argument was held on the appeal. On December 21, 2017, the Company’s appeal was denied. On January 22, 2018, the Company filed a motion for leave to appeal to the New York Court of Appeals. On February 6, 2018, Tyco opposed the Company’s motion. The Company awaits the court’s decision.

In addition to the foregoing, the Company is subject to other legal proceedings that have arisen in the ordinary course of business and have not been finally adjudicated. Although there can be no assurance in this regard, the Company believes that none of the other legal proceedings to which the Company is a party will have a material adverse effect on the Company’s results of operations, cash flows or financial condition.

Regulatory Fees Audit

The Company’s 2017 FCC Form 499-A, which reports its calendar year 2016 revenue, related to payments due to the FCC, is currently under audit by the Internal Audit Division of the Universal Service Administrative Company. At January 31, 2018 and July 31, 2017, the Company’s accrued expenses included $39.7 million and $43.5 million, respectively, for these regulatory fees for the years covered by the audit and subsequent years.

Purchase Commitments

The Company had purchase commitments of $18.7 million at January 31, 2018, including the aggregate commitment under the Reciprocal Services Agreement described below.

Reciprocal Services Agreement

In August 2017, the Company entered into a Reciprocal Services Agreement with a telecom operator in Central America for a full range of services, including, but not limited to, termination of inbound and outbound international long-distance voice calls. The Company has committed to pay such telecom operator monthly committed amounts during the term of the agreement. In addition, under certain limited circumstances, the parties may renegotiate the amount of the monthly payments. In the event the parties do not agree on re-pricing terms after good faith negotiations, then either party has the right to terminate the agreement. Pursuant to the agreement, in September 2017, the Company deposited $11.75 million into an escrow account as security for the benefit of the telecom operator, which is included in “Other current assets” in the accompanying consolidated balance sheet.

Performance Bonds

IDT Payment Services and IDT Telecom have performance bonds issued through third parties for the benefit of various states in order to comply with the states’ financial requirements for money remittance licenses and telecommunications resellers, respectively. At January 31, 2018, the Company had aggregate performance bonds of $15.1 million outstanding.

Substantially Restricted Cash and Cash Equivalents

The Company treats unrestricted cash and cash equivalents held by IDT Payment Services, which provides the Company’s international money transfer services in the United States, as substantially restricted and unavailable for other purposes. At January 31, 2018 and July 31, 2017, “Cash and cash equivalents” in the Company’s consolidated balance sheets included an aggregate of $10.0 million and $10.8 million, respectively, held by IDT Payment Services that was unavailable for other purposes.

14

Straight Path Communications Inc. Settlement Agreement and Mutual Release

The Company entered into various agreements with Straight Path prior to the Straight Path Spin-Off including a Separation and Distribution Agreement to effect the separation and provide a framework for the Company’s relationship with Straight Path after the spin-off. On September 20, 2016, the Company received a letter of inquiry from the Enforcement Bureau of the FCC requesting certain information and materials related to an investigation of potential violations by Straight Path Spectrum LLC (formerly a subsidiary of the Company and currently a subsidiary of Straight Path) in connection with licenses to operate on the 28 GHz and 39 GHz bands of the Fixed Microwave Services. The Company has cooperated with the FCC in this matter and has responded to the letter of inquiry. If the FCC were to pursue separate action against the Company, the FCC could seek to fine or impose regulatory penalties or civil liability on the Company related to activities during the period of ownership by the Company.

The Separation and Distribution Agreement provides for the Company and Straight Path to indemnify each other for certain liabilities. The Company and Straight Path each communicated that it was entitled to indemnification from the other in connection with the inquiry described above and related matters. On October 24, 2017, the Company, Straight Path, SPIP and PR-SP IP Holdings LLC (“PR-SP”), an entity owned by Howard Jonas, entered into a Settlement Agreement and Release that provides for, among other things, the settlement and mutual release of potential liabilities and claims that may exist or arise under the Separation and Distribution Agreement between the Company and Straight Path. In exchange for the mutual release, the Company paid Straight Path an aggregate of $16 million in cash, Straight Path transferred to the Company its majority ownership interest in Straight Path IP Group Holding, Inc. (“New SPIP”), which holds the equity of SPIP, the entity that holds intellectual property primarily related to communications over computer networks, subject to the right to receive 22% of the net proceeds, if any, received by SPIP from licenses, settlements, awards or judgments involving any of the patent rights and certain transfers of the patents or related rights, that will be retained by Straight Path’s stockholders (such equity interest, subject to the retained interest right, the “IP Interest”), and the Company undertook certain funding and other obligations related to SPIP. The Settlement Agreement and Release allocates (i) $10 million of the payment and the retained interest right to the settlement of claims and the mutual release and (ii) $6 million to the transfer of the IP Interest. 

Consistent with the contemplated arrangement that was previously disclosed, on October 24, 2017, the Company sold its entire majority interests in New SPIP to PR-SP in exchange for $6 million and the assumption by PR-SP of the funding and other obligations undertaken by the Company.

Note 12—Other Income (Expense), Net

Other income (expense), net consists of the following:

	Three Months Ended January 31,						Six Months Ended January 31,
	2018			2017			2018			2017
	(in thousands)
Foreign currency transaction gains (losses)	$	169		$	(729	)	$	(559	)	$	1,330
(Loss) gain on sale of marketable securities		(16	)		305			(9	)		305
Gain on investments		179			32			59			295
Other		38			(27	)		53			44
Total other income (expense), net	$	370		$	(419	)	$	(456	)	$	1,974

Note 13—Income Tax and New Jersey Corporation Business Tax

Tax Cuts and Jobs Act

On December 22, 2017, the U.S. government enacted “An Act to Provide for Reconciliation Pursuant to Titles II and V of the Concurrent Resolution on the Budget for Fiscal Year 2018”, which is commonly referred to as “The Tax Cuts and Jobs Act” (the “Tax Act”). The Tax Act reduces the U.S. federal statutory corporate tax rate from 35.0% to 21.0% effective January 1, 2018, requires companies to pay a one-time repatriation tax on earnings of certain foreign subsidiaries that were previously tax deferred (“transition tax”), and makes other changes to the U.S. income tax code. Due to the Company’s July 31 fiscal year-end, the lower corporate income tax rate is phased in, resulting in a blended U.S. federal statutory tax rate of approximately 26.9% for the Company’s fiscal year ending July 31, 2018, and 21.0% for the Company’s fiscal years thereafter.

On December 22, 2017, the SEC issued Staff Accounting Bulletin No. 118 (“SAB 118”), expressing its views regarding the Financial Accounting Standards Board (“FASB”)’s Accounting Standards Codification 740, Income Taxes, in the reporting period that includes the enactment date of the Tax Act. SAB 118 recognizes that a registrant’s review of certain income tax effects of the Tax Act may be incomplete at the time financial statements are issued for the reporting period that includes the enactment date, including interim periods therein. Specifically, SAB 118 allows a company to report provisional estimates in the reporting period that includes the enactment date if the company does not have the necessary information available, prepared, or fully analyzed for certain income tax effects of the Tax Act. The provisional estimates would be adjusted during a measurement period not to exceed 12 months from the enactment date of the Tax Act, at which time the accounting for the income tax effects of the Tax Act is required to be completed.

15

As of January 31, 2018, the Company had not completed its accounting for the income tax effects of the Tax Act; however, the Company had made a reasonable estimate of the effect on its existing AMT credit carryover. Because the AMT credit will be refundable if not utilized in the next four years, the Company reversed the valuation allowance that offset the AMT credit. As a result, in the three months ended January 31, 2018, the Company recorded a noncurrent receivable and an income tax benefit of $3.3 million for the anticipated refund. The reduction in the corporate tax rate is not expected to impact the Company’s results of operations or financial position in the foreseeable future because the income tax benefit from the reduced tax rate will be offset by the valuation allowance.

The transition tax is based on total post-1986 earnings and profits which were previously deferred from U.S. income taxes. The Company expects to utilize net operating loss carryforwards to offset any transition tax that it may incur. Therefore the Company did not record any provisional income tax expense for the transition tax for its foreign subsidiaries. At January 31, 2018, the undistributed earnings of the Company’s foreign subsidiaries continued to be permanently reinvested and the Company does not intend to repatriate any of the amounts. As a result, the Company has not provided for additional income or withholding taxes for the undistributed earnings or for any additional outside basis differences with respect to the foreign entities. The Company continues to review the anticipated impacts of the global intangible low taxed income (“GILTI”) and base erosion anti-abuse tax (“BEAT”), which are not effective until August 1, 2018. The Company has not recorded any impact associated with either GILTI or BEAT in the three months ended January 31, 2018.

The Company anticipates that its assumptions and estimates may change as a result of future guidance and interpretation from the Internal Revenue Service, the SEC, the FASB, and various other taxing jurisdictions. In particular, the Company anticipates that the U.S. state jurisdictions will continue to determine and announce their conformity or decoupling from the Tax Act, either in its entirety or with respect to specific provisions. Legislative and interpretive actions could result in adjustments to the Company’s provisional estimates when the accounting for the income tax effects of the Tax Act is completed. The Company will continue to evaluate the impact of the Tax Act on its financial statements, and will record the effect of any reasonable changes in its estimates and adjustments.

Elmion Netherlands B.V. Deferred Tax Assets

In the six months ended January 31, 2017, the Company determined that its valuation allowance on the losses of Elmion Netherlands B.V., a Netherlands subsidiary, was no longer required due to an internal reorganization that generated income and a projection of income in future periods. The Company recorded a benefit from income taxes of $16.6 million in the six months ended January 31, 2017 from the full recognition of the Elmion Netherlands B.V. deferred tax assets.

New Jersey Corporation Business Tax

In September 2017, the Company, IDT Domestic Telecom, Inc. (a subsidiary of the Company) and certain other affiliates, were certified by the New Jersey Economic Development Authority as having met all of the requirements of the Grow New Jersey Assistance Act Tax Credit Program. The corporation business tax credits to be received are a maximum of $21.1 million. The Company may claim a tax credit each tax year for ten years beginning in 2017. The tax credit can be applied to 100% of the Company’s New Jersey tax liability each year, and the unused amount of the annual credit can be carried forward. In addition, the Company may apply for a tax credit transfer certificate to sell unused tax credits to another business. The tax credits must be sold for no less than 75% of the value of the tax credits. The tax credits are subject to reduction, forfeiture and recapture if, among other things, the number of full-time employees declines below the program or statewide minimum.

Note 14—Recently Issued Accounting Standard Not Yet Adopted

In May 2014, the FASB and the International Accounting Standards Board jointly issued a comprehensive new revenue recognition standard that will supersede most of the current revenue recognition guidance under U.S. GAAP and International Financial Reporting Standards (“IFRS”). The goals of the revenue recognition project were to clarify and converge the revenue recognition principles under U.S. GAAP and IFRS and to develop guidance that would streamline and enhance revenue recognition requirements. Entities have the option of using either a full retrospective or modified retrospective approach for the adoption of the standard. The Company expects to adopt this standard on August 1, 2018 using the modified retrospective approach. The Company has identified its main revenue streams, which include Boss Revolution PIN-less international calling revenue, wholesale carrier services revenue, and domestic and international airtime top-up revenue. The Company is currently reviewing contracts and other relevant documents related to its wholesale carrier services revenue to determine how to apply the new standard to this revenue stream. The Company expects to continue its review and evaluation for its other revenue streams in fiscal 2018. Currently, the Company cannot reasonably estimate the impact that the adoption of the standard will have on its consolidated financial statements.

16

In January 2016, the FASB issued an ASU to provide more information about recognition, measurement, presentation and disclosure of financial instruments. The amendments in the ASU include, among other changes, the following: (1) equity investments (except those accounted for under the equity method or that result in consolidation) will be measured at fair value with changes in fair value recognized in net income, (2) a qualitative assessment each reporting period to identify impairment of equity investments without readily determinable fair values, (3) financial assets and financial liabilities will be presented separately by measurement category and form of financial asset on the balance sheet or the notes to the financial statements, and (4) an entity should evaluate the need for a valuation allowance on a deferred tax asset related to available-for-sale securities in combination with the entity’s other deferred tax assets. Entities will no longer be able to recognize unrealized holding gains and losses on equity securities classified as available-for-sale in other comprehensive income. In addition, a practicability exception will be available for equity investments that do not have readily determinable fair values and do not qualify for the net asset value practical expedient. These investments may be measured at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. Entities will have to reassess at each reporting period whether an investment qualifies for this practicability exception. The Company will adopt the amendments in this ASU on August 1, 2018. The Company is evaluating the impact that the ASU will have on its consolidated financial statements. 

In February 2016, the FASB issued an ASU related to the accounting for leases. The new standard establishes a right-of-use (“ROU”) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The Company will adopt the new standard on August 1, 2019. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is evaluating the impact that the new standard will have on its consolidated financial statements. 

In June 2016, the FASB issued an ASU that changes the impairment model for most financial assets and certain other instruments. For receivables, loans and other instruments, entities will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowance for losses. For available-for-sale debt securities with unrealized losses, entities will measure credit losses in a manner similar to current practice, except the losses will be recognized as allowances instead of reductions in the amortized cost of the securities. In addition, an entity will have to disclose significantly more information about allowances, credit quality indicators and past due securities. The new provisions will be applied as a cumulative-effect adjustment to retained earnings. The Company will adopt the new standard on August 1, 2020. The Company is evaluating the impact that the new standard will have on its consolidated financial statements.

In November 2016, the FASB issued an ASU that includes specific guidance on the classification and presentation of changes in restricted cash and cash equivalents in the statement of cash flows. The amendments in this ASU require that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Amounts generally described as restricted cash or restricted cash equivalents will be included with cash and cash equivalents when reconciling the beginning of the period and end of the period total amounts shown on the statement of cash flows. The ASU will be applied using a retrospective transition method to each period presented. The Company will adopt the amendments in this ASU on August 1, 2018. The adoption will impact the Company’s beginning of the period and end of the period cash and cash equivalents balance in its statement of cash flows, as well as its net cash provided by operating activities.

In January 2017, the FASB issued an ASU to clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. Under the current guidance, there are three elements of a business—inputs, processes, and outputs. While an integrated set of assets and activities (collectively referred to as a “set”) that is a business usually has outputs, outputs are not required to be present. In addition, all the inputs and processes that a seller uses in operating a set are not required if market participants can acquire the set and continue to produce outputs, for example, by integrating the acquired set with their own inputs and processes. The amendments in this ASU provide a screen to determine when a set is not a business. The screen requires that when substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single identifiable asset or a group of similar identifiable assets, the set is not a business. This screen reduces the number of transactions that need to be further evaluated. If the screen is not met, the amendments in this ASU (1) require that to be considered a business, a set must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create output and (2) remove the evaluation of whether a market participant could replace missing elements. The amendments provide a framework to assist entities in evaluating whether both an input and a substantive process are present. The framework includes two sets of criteria to consider that depend on whether a set has outputs. Although outputs are not required for a set to be a business, outputs generally are a key element of a business; therefore, the FASB has developed more stringent criteria for sets without outputs. Lastly, the ASU narrows the definition of the term output. The Company will adopt the amendments in this ASU on August 1, 2018. The Company is evaluating the impact that the new standard will have on its consolidated financial statements.

17

In May 2017, the FASB issued an ASU to provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. Pursuant to this ASU, an entity should account for the effects of a modification unless all the following are met: (1) the fair value (or calculated value or intrinsic value, if such an alternative measurement method is used) of the modified award is the same as the fair value (or calculated value or intrinsic value, if such an alternative measurement method is used) of the original award immediately before the original award is modified (if the modification does not affect any of the inputs to the valuation technique that the entity uses to value the award, the entity is not required to estimate the value immediately before and after the modification); (2) the vesting conditions of the modified award are the same as the vesting conditions of the original award immediately before the original award is modified; and (3) the classification of the modified award as an equity instrument or a liability instrument is the same as the classification of the original award immediately before the original award is modified. The Company will adopt the amendments in this ASU prospectively to an award modified on or after on August 1, 2018. The Company is evaluating the impact that the new standard will have on its consolidated financial statements.

In August 2017, the FASB issued an ASU intended to improve the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements. In addition, the ASU includes certain targeted improvements to simplify the application of hedge accounting guidance in U.S. GAAP. The amendments in this ASU are effective for the Company on August 1, 2019. Early application is permitted. Entities will apply the amendments to cash flow and net investment hedge relationships that exist on the date of adoption using a modified retrospective approach. The presentation and disclosure requirements will be applied prospectively. The Company is evaluating the impact that this ASU will have on its consolidated financial statements.

18

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following information should be read in conjunction with the accompanying consolidated financial statements and the associated notes thereto of this Quarterly Report, and the audited consolidated financial statements and the notes thereto and our Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the year ended July 31, 2017, as filed with the U.S. Securities and Exchange Commission (or SEC).

As used below, unless the context otherwise requires, the terms “the Company,” “IDT,” “we,” “us,” and “our” refer to IDT Corporation, a Delaware corporation, its predecessor, International Discount Telecommunications, Corp., a New York corporation, and their subsidiaries, collectively.

Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements that contain the words “believes,” “anticipates,” “expects,” “plans,” “intends,” and similar words and phrases. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the results projected in any forward-looking statement. In addition to the factors specifically noted in the forward-looking statements, other important factors, risks and uncertainties that could result in those differences include, but are not limited to, those discussed under Item 1A to Part I “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended July 31, 2017. The forward-looking statements are made as of the date of this report and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Investors should consult all of the information set forth in this report and the other information set forth from time to time in our reports filed with the SEC pursuant to the Securities Act of 1933 and the Securities Exchange Act of 1934, including our Annual Report on Form 10-K for the year ended July 31, 2017.

Overview

We are a multinational holding company with operations primarily in the telecommunications and payment industries. We have two reportable business segments, Telecom Platform Services and net2phone-Unified Communications as a Service, or net2phone-UCaaS (formerly known as UCaaS). The Telecom Platform Services segment provides retail telecommunications and payment offerings as well as wholesale international long distance traffic termination. The net2phone-UCaaS segment is comprised of (1) cable telephony, (2) cloud-based private branch exchange, or PBX, services offered to enterprise customers exclusively through value-added resellers, service providers, telecom agents and managed service providers, (3) Session Initiation Protocol, or SIP, trunking, which supports inbound and outbound domestic and international calling from an IP PBX, and (4) PicuP, a highly-automated business phone service that answers, routes and manages voice calls. Telecom Platform Services and net2phone-UCaaS comprise our IDT Telecom division. Operating segments not reportable individually are included in All Other. All Other includes our real estate holdings and other smaller businesses.

Since our inception, we have derived the majority of our revenues and operating expenses from IDT Telecom’s businesses. IDT Telecom’s revenues represented 99.8% and 99.9% of our total revenues in the six months ended January 31, 2018 and 2017, respectively.

On or about March 26, 2018, we expect to spin-off our subsidiary Rafael Holdings, Inc., or RHI, to our stockholders, so that RHI will be a separate publicly traded company. Approval of the spin-off by our stockholders is not required. Our Board of Directors believes that the spin-off will allow RHI to better focus on its strategic mission and that its potential can be better realized as an independent entity. The spin-off of RHI will occur by way of a pro rata distribution of RHI’s capital stock to our stockholders. On the distribution date, each of our stockholders as of the record date for the distribution of March 13, 2018 will receive one share of RHI Class A common stock for every two shares of our Class A common stock and one share of RHI Class B common stock for every two shares of our Class B common stock. Completion of the RHI spin-off is subject to receipt of a favorable opinion as to the spin-off’s tax-free status.

RHI owns the commercial real estate assets held by us and interests in two clinical stage pharmaceutical companies. The commercial real estate holdings consist of our headquarters building and its associated public garage in Newark, New Jersey, an office/data center building in Piscataway, New Jersey and a portion of a building in Israel that hosts offices for us and certain affiliates. The pharmaceutical holdings include debt interests and warrants in Rafael Pharmaceuticals, Inc., or Rafael Pharma, which is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells, and a majority equity interest in Lipomedix Pharmaceuticals Ltd., or Lipomedix, a pharmaceutical development company based in Israel. In addition, prior to the spin-off, we intend to transfer assets to RHI such that, at the time of the spin-off, RHI will have approximately $44 million in cash, cash equivalents, and marketable securities, plus $6 million in hedge fund and other investments.

19

Critical Accounting Policies

Our consolidated financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America, or U.S. GAAP. Our significant accounting policies are described in Note 1 to the consolidated financial statements included in our Annual Report on Form 10-K for fiscal 2017. The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses as well as the disclosure of contingent assets and liabilities. Critical accounting policies are those that require application of management’s most subjective or complex judgments, often as a result of matters that are inherently uncertain and may change in subsequent periods. Our critical accounting policies include those related to the allowance for doubtful accounts, goodwill, valuation of long-lived and intangible assets, income taxes and regulatory agency fees, and IDT Telecom direct cost of revenues—disputed amounts. Management bases its estimates and judgments on historical experience and other factors that are believed to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions. For additional discussion of our critical accounting policies, see our Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for fiscal 2017.

Recently Issued Accounting Standard Not Yet Adopted

In May 2014, the Financial Accounting Standards Board, or FASB, and the International Accounting Standards Board jointly issued a comprehensive new revenue recognition standard that will supersede most of the current revenue recognition guidance under U.S. GAAP and International Financial Reporting Standards, or IFRS. The goals of the revenue recognition project were to clarify and converge the revenue recognition principles under U.S. GAAP and IFRS and to develop guidance that would streamline and enhance revenue recognition requirements. Entities have the option of using either a full retrospective or modified retrospective approach for the adoption of the standard. We expect to adopt this standard on August 1, 2018 using the modified retrospective approach. We have identified our main revenue streams, which include Boss Revolution PIN-less international calling revenue, wholesale carrier services revenue, and domestic and international airtime top-up revenue. We are currently reviewing contracts and other relevant documents related to our wholesale carrier services revenue to determine how to apply the new standard to this revenue stream. We expect to continue our review and evaluation for our other revenue streams in fiscal 2018. Currently, we cannot reasonably estimate the impact that the adoption of the standard will have on our consolidated financial statements.

In January 2016, the FASB issued an ASU to provide more information about recognition, measurement, presentation and disclosure of financial instruments. The amendments in the ASU include, among other changes, the following: (1) equity investments (except those accounted for under the equity method or that result in consolidation) will be measured at fair value with changes in fair value recognized in net income, (2) a qualitative assessment each reporting period to identify impairment of equity investments without readily determinable fair values, (3) financial assets and financial liabilities will be presented separately by measurement category and form of financial asset on the balance sheet or the notes to the financial statements, and (4) an entity should evaluate the need for a valuation allowance on a deferred tax asset related to available-for-sale securities in combination with the entity’s other deferred tax assets. Entities will no longer be able to recognize unrealized holding gains and losses on equity securities classified as available-for-sale in other comprehensive income. In addition, a practicability exception will be available for equity investments that do not have readily determinable fair values and do not qualify for the net asset value practical expedient. These investments may be measured at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. Entities will have to reassess at each reporting period whether an investment qualifies for this practicability exception. We will adopt the amendments in this ASU on August 1, 2018. We are evaluating the impact that the ASU will have on our consolidated financial statements.

In February 2016, the FASB issued an ASU related to the accounting for leases. The new standard establishes a right-of-use, or ROU, model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. We will adopt the new standard on August 1, 2019. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. We are evaluating the impact that the new standard will have on our consolidated financial statements.

In June 2016, the FASB issued an ASU that changes the impairment model for most financial assets and certain other instruments. For receivables, loans and other instruments, entities will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowance for losses. For available-for-sale debt securities with unrealized losses, entities will measure credit losses in a manner similar to current practice, except the losses will be recognized as allowances instead of reductions in the amortized cost of the securities. In addition, an entity will have to disclose significantly more information about allowances, credit quality indicators and past due securities. The new provisions will be applied as a cumulative-effect adjustment to retained earnings. We will adopt the new standard on August 1, 2020. We are evaluating the impact that the new standard will have on our consolidated financial statements.

20

In November 2016, the FASB issued an ASU that includes specific guidance on the classification and presentation of changes in restricted cash and cash equivalents in the statement of cash flows. The amendments in this ASU require that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Amounts generally described as restricted cash or restricted cash equivalents will be included with cash and cash equivalents when reconciling the beginning of the period and end of the period total amounts shown on the statement of cash flows. The ASU will be applied using a retrospective transition method to each period presented. We will adopt the amendments in this ASU on August 1, 2018. The adoption will impact our beginning of the period and end of the period cash and cash equivalents balance in our statement of cash flows, as well as our net cash provided by operating activities.

In January 2017, the FASB issued an ASU to clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. Under the current guidance, there are three elements of a business—inputs, processes, and outputs. While an integrated set of assets and activities (collectively referred to as a “set”) that is a business usually has outputs, outputs are not required to be present. In addition, all the inputs and processes that a seller uses in operating a set are not required if market participants can acquire the set and continue to produce outputs, for example, by integrating the acquired set with their own inputs and processes. The amendments in this ASU provide a screen to determine when a set is not a business. The screen requires that when substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single identifiable asset or a group of similar identifiable assets, the set is not a business. This screen reduces the number of transactions that need to be further evaluated. If the screen is not met, the amendments in this ASU (1) require that to be considered a business, a set must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create output and (2) remove the evaluation of whether a market participant could replace missing elements. The amendments provide a framework to assist entities in evaluating whether both an input and a substantive process are present. The framework includes two sets of criteria to consider that depend on whether a set has outputs. Although outputs are not required for a set to be a business, outputs generally are a key element of a business; therefore, the FASB has developed more stringent criteria for sets without outputs. Lastly, the ASU narrows the definition of the term output. We will adopt the amendments in this ASU on August 1, 2018. We are evaluating the impact that the new standard will have on our consolidated financial statements.

In May 2017, the FASB issued an ASU to provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. Pursuant to this ASU, an entity should account for the effects of a modification unless all the following are met: (1) the fair value (or calculated value or intrinsic value, if such an alternative measurement method is used) of the modified award is the same as the fair value (or calculated value or intrinsic value, if such an alternative measurement method is used) of the original award immediately before the original award is modified (if the modification does not affect any of the inputs to the valuation technique that the entity uses to value the award, the entity is not required to estimate the value immediately before and after the modification); (2) the vesting conditions of the modified award are the same as the vesting conditions of the original award immediately before the original award is modified; and (3) the classification of the modified award as an equity instrument or a liability instrument is the same as the classification of the original award immediately before the original award is modified. We will adopt the amendments in this ASU prospectively to an award modified on or after on August 1, 2018. We are evaluating the impact that the new standard will have on our consolidated financial statements.

In August 2017, the FASB issued an ASU intended to improve the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements. In addition, the ASU includes certain targeted improvements to simplify the application of hedge accounting guidance in U.S. GAAP. The amendments in this ASU are effective for us on August 1, 2019. Early application is permitted. Entities will apply the amendments to cash flow and net investment hedge relationships that exist on the date of adoption using a modified retrospective approach. The presentation and disclosure requirements will be applied prospectively. We are evaluating the impact that this ASU will have on our consolidated financial statements.

Results of Operations

Three and Six Months Ended January 31, 2018 Compared to Three and Six Months Ended January 31, 2017

We evaluate the performance of our operating business segments based primarily on income (loss) from operations. Accordingly, the income and expense line items below income (loss) from operations are only included in our discussion of the consolidated results of operations.

21

Telecom Platform Services Segment

Beginning in the first quarter of fiscal 2018, the Telecom Platform Services segment includes Consumer Phone Services, which was previously reported as a separate segment. Consumer Phone Services provides consumer local and long distance services in certain U.S. states. Comparative results have been reclassified and restated as if Consumer Phone Services was included in Telecom Platform Services in all periods presented.

Telecom Platform Services, which represented 97.8% and 97.9% of our total revenues in the six months ended January 31, 2018 and 2017, respectively, markets and distributes multiple communications and payment services across three broad business verticals:

● Retail Communications provides international long-distance calling products primarily to foreign-born communities worldwide, with its core markets in the United States;

● Wholesale Carrier Services is a global telecom carrier, terminating international long distance calls around the world for Tier 1 fixed line and mobile network operators, as well as other service providers; and

● Payment Services provides payment offerings, including international and domestic airtime top-up and international money transfer.

	Three months ended January 31,				Change						Six months ended January 31,				Change
	2018		2017		$			%			2018		2017		$			%
	(in millions)
Revenues	$	387.1	$	359.9	$	27.2			7.5	%	$	772.1	$	721.4	$	50.7			7.0	%
Direct cost of revenues		334.6		308.0		26.6			8.6			668.6		617.7		50.9			8.2
Selling, general and administrative		43.6		40.7		2.9			6.8			85.7		81.8		3.9			4.7
Depreciation		4.1		4.0		0.1			3.5			8.1		8.2		(0.1	)		(0.7	)
Severance		0.2		—		0.2			nm			0.6		—		0.6			nm
Income from operations	$	4.6	$	7.2	$	(2.6	)		(36.2	)%	$	9.1	$	13.7	$	(4.6	)		(33.4	)%

nm—not meaningful

Revenues. Telecom Platform Services’ revenues, minutes of use and average revenue per minute for the three months ended January 31, 2018 and 2016 consisted of the following:

	Three months ended January 31,				Change						Six months ended January 31,				Change
	2018		2017		$/#			%			2018		2017		$/#			%
	(in millions, except revenue per minute)
Telecom Platform Services Revenues
Retail Communications	$	145.2	$	154.6	$	(9.4	)		(6.1	)%	$	291.4	$	313.1	$	(21.7	)		(6.9	)%
Wholesale Carrier Services		172.5		145.8		26.7			18.3			343.0		289.1		53.9			18.6
Payment Services		69.4		59.5		9.9			16.5			137.7		119.2		18.5			15.5
Total Telecom Platform Services revenues	$	387.1	$	359.9	$	27.2			7.5	%	$	772.1	$	721.4	$	50.7			7.0	%
Minutes of use
Retail Communications		1,416		1,708		(292	)		(17.1	)%		2,889		3,537		(648	)		(18.3	)%
Wholesale Carrier Services		5,385		5,057		328			6.5			10,601		9,405		1,196			12.7
Total minutes of use		6,801		6,765		36			0.5	%		13,490		12,942		548			4.2	%
Average revenue per minute
Retail Communications	$	0.1026	$	0.0905	$	0.0121			13.3	%	$	0.1009	$	0.0885	$	0.0124			14.0	%
Wholesale Carrier Services		0.0320		0.0288		0.0032			11.1			0.0324		0.0307		0.0017			5.2

22

Retail Communications’ revenue decreased 6.1% and 6.9% in the three and six months ended January 31, 2018, respectively, compared to the similar periods in fiscal 2017, and Retail Communications’ minutes of use decreased 17.1% and 18.3% in the three and six months ended January 31, 2018, respectively, compared to the similar periods in fiscal 2017. The decrease in Retail Communications’ revenues and minutes of use was primarily due to increased competition from wireless network operators, mobile virtual network operators and alternative communications solutions such as over-the-top voice and messaging services. Revenue from our Boss Revolution international calling service, which is Retail Communications’ most significant offering, declined 4.2% and 4.8% in the three and six months ended January 31, 2018, respectively, compared to the similar periods in fiscal 2017, and Boss Revolution’s minutes of use declined 14.1% and 15.3% in the three and six months ended January 31, 2018, respectively, compared to the similar periods in fiscal 2017. In addition, the decrease in Retail Communications’ revenue and minutes of use in the three and six months ended January 31, 2018 compared to the similar periods in fiscal 2017 was due to continuing declines in Europe, South America and Asia, and continuing declines from traditional disposable calling cards in the U.S. Retail Communications’ revenue comprised 37.8% and 43.4% of Telecom Platform Services’ revenue in the six months ended January 31, 2018 and 2017, respectively.

Wholesale Carrier Services’ revenue increased 18.3% and 18.6% in the three and six months ended January 31, 2018, respectively, compared to the similar periods in fiscal 2017, and Wholesale Carrier Services’ minutes of use increased 6.5% and 12.7% in the three and six months ended January 31, 2018, respectively, compared to the similar periods in fiscal 2017, due to an increase in traditional carrier minutes of use and revenues. Wholesale Carrier Services’ revenue comprised 44.4% and 40.1% of Telecom Platform Services’ revenue in the six months ended January 31, 2018 and 2017, respectively.

Payment Services’ revenue increased 16.5% and 15.5% in the three and six months ended January 31, 2018, respectively, compared to the similar periods in fiscal 2017 due to increases in revenue from our international and domestic airtime top-up service, our international money transfer service (specifically transactions originating from our direct to consumer channels), and our National Retail Solutions point-of-sale terminal business. The increase in revenues from airtime top-up in the three and six months ended January 31, 2018 compared to the similar periods in fiscal 2017 reflected growth from new mobile partners and diversification of airtime top-up offerings. We have money transmitter licenses in 47 of the 49 states that require such a license, as well as in Puerto Rico and Washington, D.C. Future growth in Payment Services is expected from the Boss Revolution Money app that features international money transfers, airtime top-up and electronic gift cards. National Retail Solutions is also expected to continue expanding. Payment Services’ revenue comprised 17.8% and 16.5% of Telecom Platform Services’ revenue in the six months ended January 31, 2018 and 2017, respectively.

	Three months ended January 31,									Six months ended January 31,
	2018			2017			Change			2018			2017			Change
Telecom Platform Services
Direct cost of revenues as a percentage of revenues		86.5	%		85.6	%		0.9	%		86.6	%		85.6	%		1.0	%

Direct Cost of Revenues. Direct cost of revenues in Telecom Platform Services increased in the three and six months ended January 31, 2018 compared to the similar periods in fiscal 2017 mainly due to the 6.5% and 12.7% increase in Wholesale Carrier Services’ minutes of use in the three and six months ended January 31, 2018, respectively, compared to the similar periods in fiscal 2017. Direct cost of revenues as a percentage of revenues in Telecom Platform Services increased 90 and 100 basis points in the three and six months ended January 31, 2018, respectively, compared to the similar periods in fiscal 2017 primarily due to a shift in the revenue mix within our Telecom Platform Services segment towards Wholesale Carrier Services, which typically exhibits higher direct cost of revenues as a percentage of revenues than our Retail Communications’ offerings.

Selling, General and Administrative. Selling, general and administrative expense in our Telecom Platform Services segment increased in the three months ended January 31, 2018 compared to the similar period in fiscal 2017 primarily due to increases in employee compensation and credit card charges. Selling, general and administrative expense in our Telecom Platform Services segment increased in the six months ended January 31, 2018 compared to the similar period in fiscal 2017 primarily due to increases in employee compensation and credit card charges, partially offset by a decrease in marketing expense. The increase in credit card charges relates to increases in Boss Revolution and international money transfer direct to consumer transactions. As a percentage of Telecom Platform Services’ revenue, Telecom Platform Services’ selling, general and administrative expense decreased to 11.2% from 11.3% in the three months ended January 31, 2018 and 2017, respectively, and decreased to 11.1% from 11.3% in the six months ended January 31, 2018 and 2017, respectively.

Depreciation and Amortization. Depreciation and amortization expense increased 3.5% in the three months ended January 31, 2018 compared to the similar period in fiscal 2017, and was substantially unchanged in the six months ended January 31, 2018 compared to the similar period in fiscal 2017. Depreciation and amortization expense increased due to increases in depreciation of capitalized costs of consultants and employees developing internal use software.

Severance. In the three and six months ended January 31, 2018, Telecom Platform Services completed an adjustment to its workforce and incurred severance expense of $0.2 million and $0.6 million, respectively.

23

net2phone-UCaaS Segment

	Three months ended January 31,						Change						Six months ended January 31,						Change
	2018			2017			$			%			2018			2017			$			%
	(in millions)
Revenues	$	8.3		$	7.1		$	1.2			16.2	%	$	16.1		$	14.3		$	1.8			12.7	%
Direct cost of revenues		2.6			2.9			(0.3	)		(10.7	)		5.1			6.2			(1.1	)		(17.7	)
Selling, general and administrative		5.3			3.8			1.5			40.0			10.0			7.1			2.9			41.0
Depreciation		1.2			0.9			0.3			31.4			2.5			1.6			0.9			51.5
Loss from operations	$	(0.8	)	$	(0.5	)	$	(0.3	)		(70.3	)%	$	(1.5	)	$	(0.6	)	$	(0.9	)		(129.3	)%

Revenues. net2phone-UCaaS’ revenue increased 16.2% and 12.7% in the three and six months ended January 31, 2018, respectively, compared to the similar periods in fiscal 2017 primarily due to continued growth from its cloud-based communications offering – both in the U.S. and in South America. In light of the strong growth in the cloud-based communications offering in Argentina and Brazil, net2phone-UCaaS anticipates additional international expansion in South America and Asia in fiscal 2018.

	Three months ended January 31,									Six months ended January 31,
	2018			2017			Change			2018			2017			Change
net2phone-UCaaS
Direct cost of revenues as a percentage of revenues		31.5	%		41.0	%		(9.5	)%		31.8	%		43.5	%		(11.7	)%

Direct Cost of Revenues. Direct cost of revenues in net2phone-UCaaS decreased in the three and six months ended January 31, 2018 compared to the similar periods in fiscal 2017 primarily because of a decrease in the direct cost of revenues in cable telephony service, partially offset by an increase in the direct cost of revenues of cloud-based communications. Direct cost of revenues as a percentage of revenues in net2phone-UCaaS decreased 950 and 1,170 basis points in the three and six months ended January 31, 2018, respectively, compared to the similar periods in fiscal 2017 primarily because of the decrease in the direct cost of revenues in cable telephony service, as well as decreases in direct cost of revenues as a percentage of revenues in cloud-based communications and SIP trunking.

Selling, General and Administrative. Selling, general and administrative expense in our net2phone-UCaaS segment increased in the three and six months ended January 31, 2018 compared to the similar periods in fiscal 2017 due to an increase in employee compensation resulting from an increase in the number of sales and information technology employees. We increased employees and compensation in our net2phone-UCaaS segment as we invested in the growth of net2phone-UCaaS’ lines of business.

Depreciation. The increase in depreciation expense in the net2phone-UCaaS segment in the three and six months ended January 31, 2018 compared to the similar periods in fiscal 2017 was due to increases in depreciation of capitalized costs of consultants and employees developing internal use software to support our new products.

All Other

Currently, operating segments not reportable individually are included in All Other.

	Three months ended January 31,					Change						Six months ended January 31,					Change
	2018			2017		$			%			2018			2017		$			%
	(in millions)
Revenues	$	0.5		$	0.5	$	—			5.8	%	$	1.2		$	1.0	$	0.2			23.0	%
Direct cost of revenues		—			—		—			—			—			—		—			—
Selling, general and administrative		1.1			—		1.1			nm			2.0			—		2.0			nm
Depreciation		0.4			0.4		—			3.4			0.8			0.8		—			3.2
(Loss) income from operations	$	(1.0	)	$	0.1	$	(1.1	)		nm		$	(1.6	)	$	0.2	$	(1.8	)		nm

nm—not meaningful

Revenues. In April 2016, we entered into two leases with tenants for space in our headquarters building at 520 Broad Street, Newark, New Jersey. One lease is for a portion of the sixth floor for an eleven-year term, of which the first six years are non-cancellable. The other lease is for a portion of the ground floor and basement for a term of ten years and seven months. The tenant under this lease has the right to extend the term for three consecutive periods of five years each. Rental income from the first lease commenced in December 2016, and rental income from the second lease commenced in March 2017. In addition, in April 2017, we entered into a third lease for another portion of the ground floor for a term of ten years, four months. Rental income from the third lease commenced in March 2018.

24

Selling, General and Administrative. Selling, general and administrative expense increased in the three and six months ended January 31, 2018 compared to the similar periods in fiscal 2017 primarily due to increases in expenses related to RHI, including Lipomedix, and our commercial real estate. We began consolidating Lipomedix in November 2017 after we purchased additional shares and increased our ownership to 50.6% of the issued and outstanding ordinary shares of Lipomedix. Selling, general and administrative expense of Lipomedix in the three and six months ended January 31, 2018 was $0.4 million.

Corporate

	Three months ended January 31,				Change						Six months ended January 31,				Change
	2018		2017		$			%			2018		2017		$		%
	(in millions)
General and administrative	$	2.4	$	2.8	$	(0.4	)		(13.4	)%	$	4.8	$	3.9	$	0.9		23.7	%
Other operating expense		0.9		0.9		—			4.8			1.6		1.1		0.5		49.3
Loss from operations	$	3.3	$	3.7	$	(0.4	)		(11.4	)%	$	6.4	$	5.0	$	1.4		29.9	%

Corporate costs include compensation, consulting fees, treasury and accounts payable, tax and accounting services, human resources and payroll, corporate purchasing, corporate governance including Board of Directors’ fees, internal and external audit, investor relations, corporate insurance, corporate legal, business development, and other corporate-related general and administrative expenses, including, among others, facilities costs, charitable contributions and travel. Corporate does not generate any revenues, nor does it incur any direct cost of revenues.

General and Administrative. The decrease in Corporate general and administrative expense in the three months ended January 31, 2018 compared to the similar period in fiscal 2017 was primarily due to decreases in employee compensation and stock-based compensation expense, partially offset by an increase in legal fees. The increase in Corporate general and administrative expense in the six months ended January 31, 2018 compared to the similar period in fiscal 2017 was primarily due to increases in legal fees and employee compensation, partially offset by a decrease in stock-based compensation expense. As a percentage of our total consolidated revenues, Corporate general and administrative expense were 0.6% and 0.8% in the three months ended January 31, 2018 and 2017, respectively, and 0.6% and 0.5% in the six months ended January 31, 2018 and 2017, respectively.

Other Operating Expense. On July 31, 2013, we completed a pro rata distribution of the common stock of our former subsidiary Straight Path Communications Inc., or Straight Path, to our stockholders. In the three and six months ended January 31, 2018, we incurred legal fees of $0.2 million and $1.0 million, respectively, related to the Straight Path stockholders’ putative class action and derivative complaint. In addition, in the three and six months ended January 31, 2018, we incurred fees of $0.6 million related to other legal matters. In the three and six months ended January 31, 2017, we incurred legal fees of $0.9 million and $1.1 million, respectively, related to a letter of inquiry from the Federal Communications Commission, or FCC, in connection with its investigation of potential license violations by Straight Path Spectrum LLC (a subsidiary of Straight Path and formerly a subsidiary of ours). (See Note 11 to the Consolidated Financial Statements included in Item 1 to Part I of the Quarterly Report on Form 10-Q).

Consolidated

The following is a discussion of our consolidated stock-based compensation expense, and our consolidated income and expense line items below income from operations.

Stock-Based Compensation Expense. Stock-based compensation expense included in consolidated selling, general and administrative expenses was $1.0 million and $1.4 million in the three months ended January 31, 2018 and 2017, respectively, and $1.8 million and $2.1 million in the six months ended January 31, 2018 and 2017, respectively. At January 31, 2018, unrecognized compensation cost related to non-vested stock-based compensation, including stock options and restricted stock, was an aggregate of $4.1 million. The unrecognized compensation cost is expected to be recognized over the remaining vesting period that ends in 2020.

25

	Three months ended January 31,						Change						Six months ended January 31,						Change
	2018			2017			$			%			2018			2017			$			%
	(in millions)
(Loss) income from operations	$	(0.5	)	$	3.1		$	(3.6	)		(115.3	)%	$	(0.4	)	$	8.3		$	(8.7	)		(104.8	)%
Interest income, net		0.3			0.3			—			(7.4	)		0.6			0.6			—			6.4
Other income (expense), net		0.4			(0.4	)		0.8			188.3			(0.4	)		2.0			(2.4	)		(123.1	)
Benefit from (provision for) income taxes		1.5			(1.7	)		3.2			186.0			0.1			12.7			(12.6	)		(99.2	)
Net income (loss)		1.7			1.3			0.4			34.4			(0.1	)		23.6			(23.7	)		(100.5	)
Net income attributable to noncontrolling interests		(0.2	)		(0.4	)		0.2			54.5			(0.5	)		(0.8	)		0.3			38.0
Net income (loss) attributable to IDT Corporation	$	1.5		$	0.9		$	0.6			73.3	%	$	(0.6	)	$	22.8		$	(23.4	)		(102.5	)%

Other Income (Expense), net. Other income (expense), net consists of the following:

	Three months ended January 31,					Six months ended January 31,
	2018		2017			2018			2017
	(in millions)
Foreign currency transaction gains (losses)	$	0.2	$	(0.7	)	$	(0.6	)	$	1.3
Gain on sale of marketable securities		—		0.3			—			0.3
Gain on investments		0.2		—			0.1			0.3
Other		—		—			0.1			0.1
Total other income (expense), net	$	0.4	$	(0.4	)	$	(0.4	)	$	2.0

Benefit from (Provision for) Income Taxes. On December 22, 2017, the U.S. government enacted “An Act to Provide for Reconciliation Pursuant to Titles II and V of the Concurrent Resolution on the Budget for Fiscal Year 2018”, which is commonly referred to as “The Tax Cuts and Jobs Act”, or the Tax Act. The Tax Act provides for comprehensive tax legislation that reduces the U.S. federal statutory corporate tax rate from 35.0% to 21.0% effective January 1, 2018, requires companies to pay a one-time repatriation tax, or transition tax, on earnings of certain foreign subsidiaries that were previously tax deferred, and makes other changes to the U.S. income tax code. Due to our July 31 fiscal year-end, the lower corporate income tax rate is phased in, resulting in a blended U.S. federal statutory tax rate of approximately 26.9% for our fiscal year ending July 31, 2018, and 21.0% for our fiscal years thereafter.

On December 22, 2017, the SEC issued Staff Accounting Bulletin No. 118, or SAB 118, expressing its views regarding the FASB’s Accounting Standards Codification 740, Income Taxes, in the reporting period that includes the enactment date of the Tax Act. SAB 118 recognizes that a registrant’s review of certain income tax effects of the Tax Act may be incomplete at the time financial statements are issued for the reporting period that includes the enactment date, including interim periods therein. Specifically, SAB 118 allows a company to report provisional estimates in the reporting period that includes the enactment date if the company does not have the necessary information available, prepared, or fully analyzed for certain income tax effects of the Tax Act. The provisional estimates would be adjusted during a measurement period not to exceed 12 months from the enactment date of the Tax Act, at which time the accounting for the income tax effects of the Tax Act is required to be completed.

As of January 31, 2018, we had not completed our accounting for the income tax effects of the Tax Act; however, we had made a reasonable estimate of the effect on our existing AMT credit carryover. Because the AMT credit will be refundable if not utilized in the next four years, we reversed the valuation allowance that offset the AMT credit. As a result, in the three months ended January 31, 2018, we recorded a noncurrent receivable and an income tax benefit of $3.3 million for the anticipated refund. The reduction in the corporate tax rate is not expected to impact our results of operations or financial position in the foreseeable future because the income tax benefit from the reduced tax rate will be offset by the valuation allowance.

The transition tax is based on total post-1986 earnings and profits which were previously deferred from U.S. income taxes. We expect to utilize net operating loss carryforwards to offset any transition tax that we may incur. Therefore we did not record any provisional income tax expense for the transition tax for our foreign subsidiaries. At January 31, 2018, the undistributed earnings of our foreign subsidiaries continued to be permanently reinvested and we do not intend to repatriate any of the amounts. As a result, we have not provided for additional income or withholding taxes for the undistributed earnings or for any additional outside basis differences with respect to the foreign entities. We continue to review the anticipated impacts of the global intangible low taxed income, or GILTI, and base erosion anti-abuse tax, or BEAT, which are not effective until August 1, 2018. We have not recorded any impact associated with either GILTI or BEAT in the three months ended January 31, 2018.

26

We anticipate that our assumptions and estimates may change as a result of future guidance and interpretation from the Internal Revenue Service, the SEC, the FASB, and various other taxing jurisdictions. In particular, we anticipate that the U.S. state jurisdictions will continue to determine and announce their conformity or decoupling from the Tax Act, either in its entirety or with respect to specific provisions. Legislative and interpretive actions could result in adjustments to our provisional estimates when the accounting for the income tax effects of the Tax Act is completed. We will continue to evaluate the impact of the Tax Act on our financial statements, and will record the effect of any reasonable changes in our estimates or adjustments.

In the six months ended January 31, 2017, we determined that our valuation allowance on the losses of Elmion Netherlands B.V., or Elmion, a Netherlands subsidiary, was no longer required due to an internal reorganization that generated income and a projection that the income would continue. We recorded a benefit from income taxes of $16.6 million in the six months ended January 31, 2017 from the full recognition of the Elmion deferred tax assets.

The change in income tax expense in the three and six months ended January 31, 2018 compared to the similar periods in fiscal 2017, excluding the benefits from income taxes in the three and six months ended January 31, 2018 and in the six months ended January 31, 2017, was generally due to the differences in the tax rates in the jurisdictions where the results were recorded.

Net Income Attributable to Noncontrolling Interests. The change in the net income attributable to noncontrolling interests in the three and six months ended January 31, 2018 compared to the similar periods in fiscal 2017 was primarily due to a decrease in the net income attributable to the noncontrolling interests in certain IDT Telecom subsidiaries, as well as net loss attributable to the noncontrolling interests in Lipomedix in the three and six months ended January 31, 2018. We began consolidating Lipomedix in November 2017.

Liquidity and Capital Resources

General

We currently expect our cash from operations in the next twelve months and the balance of cash, cash equivalents and marketable securities that we held at January 31, 2018 to be sufficient to meet our currently anticipated working capital and capital expenditure requirements during the twelve-month period ending January 31, 2019.

At January 31, 2018, we had cash, cash equivalents and marketable securities of $100.3 million and working capital (current assets in excess of current liabilities) of $1.1 million. At January 31, 2018, we also had $8.8 million in investments in hedge funds, which were included in “Investments” in our consolidated balance sheet.

On or about March 26, 2018, we expect to spin-off our wholly-owned subsidiary, RHI, to our stockholders. RHI owns certain commercial real estate assets and interests in Rafael Pharma and Lipomedix. Prior to the spin-off, we intend to transfer assets to RHI such that, at the time of the spin-off, RHI will have approximately $44 million in cash, cash equivalents, and marketable securities, plus $6 million in hedge fund and other investments.

We treat unrestricted cash and cash equivalents held by IDT Payment Services as substantially restricted and unavailable for other purposes. At January 31, 2018, “Cash and cash equivalents” in our consolidated balance sheet included an aggregate of $10.0 million held by IDT Payment Services that was unavailable for other purposes.

We have not recorded U.S. income tax expense for foreign earnings, since such earnings are permanently reinvested outside the United States. Upon distribution of these foreign earnings to our domestic entities, we may be subject to U.S. income taxes and withholding of foreign taxes, however, it is not practicable to determine the amount, if any, which would be paid.

	Six months ended January 31,
	2018			2017
	(in millions)
Cash flows (used in) provided by:
Operating activities	$	(27.0	)	$	(0.8	)
Investing activities		0.9			(21.0	)
Financing activities		(10.2	)		(9.3	)
Effect of exchange rate changes on cash and cash equivalents		0.6			(0.9	)
Decrease in cash and cash equivalents	$	(35.7	)	$	(32.0	)

Operating Activities

Our cash flow from operations varies significantly from quarter to quarter and from year to year, depending on our operating results and the timing of operating cash receipts and payments, specifically trade accounts receivable and trade accounts payable.

27

Gross trade accounts receivable increased to $74.3 million at January 31, 2018 from $67.6 million at July 31, 2017 primarily due to a $6.8 million increase in IDT Telecom’s gross trade accounts receivable balance. The increase in IDT Telecom’s gross trade accounts receivable balance was primarily due to amounts billed in in the six months ended January 31, 2018 in excess of collections during the period, and the effect of changes in foreign currency exchange rates.

Deferred revenue as a percentage of total revenues varies from period to period depending on the mix and the timing of revenues. Deferred revenue arises from IDT Telecom’s sales of prepaid products. Deferred revenue decreased to $71.8 million at January 31, 2018 from $76.5 million at July 31, 2017 primarily due to a decrease in the IDT Telecom U.S. Boss Revolution balance.

On September 20, 2016, we received a letter of inquiry from the Enforcement Bureau of the FCC requesting certain information and materials related to an investigation of potential violations by Straight Path Spectrum LLC in connection with licenses to operate on the 28 GHz and 39 GHz bands of the Fixed Microwave Services. We have cooperated with the FCC in this matter and have responded to the letter of inquiry. The FCC could seek to fine or impose regulatory penalties or civil liability on us related to activities during the period of ownership by us.

The Separation and Distribution Agreement related to the spin-off of Straight Path provides for us and Straight Path to indemnify each other for certain liabilities. We and Straight Path each communicated that it was entitled to indemnification from the other in connection with the inquiry described above and related matters. On October 24, 2017, we, Straight Path, Straight Path IP Group, Inc., or SPIP, and PR-SP IP Holdings LLC, or PR-SP, an entity owned by Howard Jonas, entered into a Settlement Agreement and Release that provides for, among other things, the settlement and mutual release of potential liabilities and claims that may exist or arise under the Separation and Distribution Agreement between us and Straight Path. In exchange for the mutual release, we paid Straight Path an aggregate of $16 million in cash, Straight Path transferred to us its majority ownership interest in Straight Path IP Group Holding, Inc., or New SPIP, which holds the equity of SPIP, the entity that holds intellectual property primarily related to communications over computer networks, subject to the right to receive 22% of the net proceeds, if any, received by SPIP from licenses, settlements, awards or judgments involving any of the patent rights and certain transfers of the patents or related rights, that will be retained by Straight Path’s stockholders (such equity interest, subject to the retained interest right, the “IP Interest”), and we undertook certain funding and other obligations related to SPIP. The Settlement Agreement and Release allocates (i) $10 million of the payment and the retained interest right to the settlement of claims and the mutual release and (ii) $6 million to the transfer of the IP Interest. In the accompanying consolidated statement of cash flows in the six months ended January 31, 2018, $10 million of the aggregate payment to Straight Path was included in operating activities and $6 million of the aggregate payment was included in investing activities.

In August 2017, we entered into a Reciprocal Services Agreement with a telecom operator in Central America for a full range of services, including, but not limited to, termination of inbound and outbound international long-distance voice calls. We have committed to pay such telecom operator monthly committed amounts during the term of the agreement. In addition, under certain limited circumstances, the parties may renegotiate the amount of the monthly payments. In the event the parties do not agree on re-pricing terms after good faith negotiations, then either party has the right to terminate the agreement. Pursuant to the agreement, in September 2017, we deposited $11.75 million into an escrow account as security for the benefit of the telecom operator, which was included in operating activities in the accompanying consolidated statement of cash flows.

Investing Activities

Our capital expenditures were $10.9 million and $10.5 million in the six months ended January 31, 2018 and 2017, respectively. We currently anticipate that total capital expenditures for the twelve-month period ending January 31, 2019 will be between $21 million to $23 million. We expect to fund our capital expenditures with our net cash provided by operating activities and cash, cash equivalents and marketable securities on hand.

On October 24, 2017, we sold our entire majority interests in New SPIP to PR-SP in exchange for $6 million and the assumption by PR-SP of our funding and other obligations. As described above, $6 million of the aggregate payment to Straight Path that was allocated to the transfer of the IP Interest was included in investing activities in the six months ended January 31, 2018.

On December 23, 2016, we acquired all of the outstanding shares of Live Ninja, a business communications company that provides chat and messaging capabilities for small and medium-sized businesses with the ability to transfer a conversation from one channel of communications (for example, the web) to another (such as a mobile phone). We paid $2.0 million at closing, and expect to pay an additional $2.5 million through December 2018 for fixed and contingent payment obligations. The cash paid for the acquisition, net of cash acquired was $1.8 million.

28

In the six months ended January 31, 2017, we used cash of $8.3 million for additional investments. In September 2016, Rafael Pharma issued to our 50%-owned subsidiary, CS Pharma Holdings, LLC, or CS Pharma, its convertible Series D Note with a principal amount of $10 million, representing the $8 million investment funded on such date plus the conversion of $2 million principal amount convertible promissory notes issued in connection with a prior funding.

Purchases of marketable securities were $19.8 million and $17.2 million in the six months ended January 31, 2018 and 2017, respectively. Proceeds from maturities and sales of marketable securities were $31.6 million and $16.8 million in the six months ended January 31, 2018 and 2017, respectively.

Financing Activities

In the six months ended January 31, 2018, we paid cash dividends of $0.38 per share on our Class A common stock and Class B common stock, or $9.4 million in total. In the six months ended January 31, 2017, we paid cash dividends of $0.38 per share on our Class A common stock and Class B common stock, or $8.8 million in total. On March 5, 2018, our Board of Directors declared a dividend of $0.09 per share for the second quarter of fiscal 2018 to holders of our Class A common stock and Class B common stock. The dividend will be paid on or about March 23, 2018 to stockholders of record as of the close of business on March 19, 2018. In light of our intention to continue to invest in our growth initiatives and the impact of the RHI spin-off on our balance sheet, our Board of Directors reduced the dividend for the second quarter of fiscal 2018 from the quarterly dividend of $0.19 per share that was paid in the first two quarters of fiscal 2018.

We distributed cash of $0.7 million and $0.8 million in the six months ended January 31, 2018 and 2017, respectively, to the holders of noncontrolling interests in certain of our subsidiaries.

Our subsidiary, IDT Telecom, Inc., entered into a credit agreement, dated July 12, 2012, with TD Bank, N.A. for a line of credit facility for up to a maximum principal amount of $25.0 million. The credit agreement was amended as of January 31, 2018. IDT Telecom may use the proceeds to finance working capital requirements, acquisitions and for other general corporate purposes. The line of credit facility is secured by primarily all of IDT Telecom’s assets. The principal outstanding bears interest per annum, at the option of IDT Telecom, at either (a) the U.S. Prime Rate less 125 basis points, or (b) the LIBOR rate adjusted by the Regulation D maximum reserve requirement plus 125 basis points. Interest is payable monthly and all outstanding principal and any accrued and unpaid interest is due on the maturity date of January 31, 2020. At January 31, 2018 and July 31, 2017, there were no amounts outstanding under the facility. We intend to borrow under the facility from time to time. In the six months ended January 31, 2018, we borrowed and repaid an aggregate of $19.1 million under the facility. IDT Telecom pays a quarterly unused commitment fee of 0.325% per annum on the average daily balance of the unused portion of the $25.0 million commitment. IDT Telecom is required to comply with various affirmative and negative covenants as well as maintain certain financial targets and ratios during the term of the line of credit, including restrictions on dividend payments on IDT Telecom capital stock and restrictions on IDT Telecom’s aggregate loans and advances to affiliates or subsidiaries.

We received proceeds from the exercise of our stock options of $0.8 million in the six months ended January 31, 2017, for which we issued 73,471 shares of our Class B common stock.

In connection with our investment in Rafael Pharma, our subsidiary CS Pharma issued member interests to third parties in exchange for cash investment in CS Pharma of $10 million. We hold a 50% interest in CS Pharma and we are the managing member. At July 31, 2016, CS Pharma had received $8.8 million, which was included in “Other current liabilities” pending the issuance of the member interests. In the six months ended January 31, 2017, CS Pharma received an additional $1.2 million from the sale of its member interests.

In the six months ended January 31, 2018 and 2017, we paid $0.1 million and $1.8 million, respectively, to repurchase 5,170 and 94,338 shares, respectively, of our Class B common stock that were tendered by employees of ours to satisfy the employees’ tax withholding obligations in connection with the lapsing of restrictions on awards of restricted stock. Such shares were repurchased by us based on their fair market value on the trading day immediately prior to the vesting date.

We have a stock repurchase program for the repurchase of up to an aggregate of 8.0 million shares of our Class B common stock. There were no repurchases under the program in the six months ended January 31, 2018 or 2017. At January 31, 2018, 8.0 million shares remained available for repurchase under the stock repurchase program.

Other Sources and Uses of Resources

On June 22, 2017, IDT Telecom, Inc. entered into a Share Purchase Agreement with JAR Fintech Limited and JAR Capital Limited to sell the capital stock of IDT Financial Services Holding Limited, a company incorporated under the laws of Gibraltar and a wholly-owned subsidiary of IDT Telecom, to JAR Fintech Limited. IDT Financial Services Holding Limited is the sole shareholder of IDT Financial Services Limited, our Gibraltar-based bank. The Share Purchase Agreement provides for an aggregate purchase price for the outstanding equity interests of IDT Financial Services Holding Limited of £2.9 million ($4.1 million at January 31, 2018) plus an amount equal to the value of IDT Financial Services Holding Limited’s net assets, to be paid at closing, subject to adjustments relating to customer assets of IDT Financial Services Holding Limited. The net asset value of IDT Financial Services Holding Limited was $14.5 million at January 31, 2018. A portion of the purchase price will be placed in escrow and released to IDT Telecom once all of the conditions have been met under the Share Purchase Agreement. The sale is expected to close in the second quarter of calendar 2018, subject to regulatory approval and other customary conditions set forth in the Share Purchase Agreement. The remaining closing conditions are outside of our control and there can be no assurance that the sale will be completed.

29

We intend to, where appropriate, make strategic investments and acquisitions to complement, expand, and/or enter into new businesses. In considering acquisitions and investments, we search for opportunities to profitably grow our existing businesses and/or to add qualitatively to the range and diversification of businesses in our portfolio. At this time, we cannot guarantee that we will be presented with acquisition opportunities that meet our return on investment criteria, or that our efforts to make acquisitions that meet our criteria will be successful.

Contractual Obligations and Other Commercial Commitments

The following table quantifies our future contractual obligations and commercial commitments at January 31, 2018:

Payments Due by Period (in millions)	Total		Less than 1 year		1–3 years		4–5 years		After 5 years
Operating leases	$	6.4	$	2.9	$	2.1	$	0.7	$	0.7
Revolving credit facility (1)		0.2		0.1		0.1		—		—
Purchase commitments (2)		18.7		18.7		—		—		—
Total contractual obligations (3)	$	25.3	$	21.7	$	2.2	$	0.7	$	0.7

(1) Revolving credit facility includes estimated fees on the unused commitment at January 31, 2018.

(2) Purchase commitments include the aggregate commitment under the Reciprocal Services Agreement with a telecom operator in Central America for a full range of services, including, but not limited to, termination of inbound and outbound international long-distance voice calls.

(3) The above table does not include an aggregate of $15.1 million in performance bonds due to the uncertainty of the amount and/or timing of any such payments.

Off-Balance Sheet Arrangements

We do not have any “off-balance sheet arrangements,” as defined in relevant SEC regulations that are reasonably likely to have a current or future effect on our financial condition, results of operations, liquidity, capital expenditures or capital resources, other than the following.

In connection with our spin-off of Straight Path, in July 2013, we and Straight Path entered into various agreements prior to the spin-off including a Separation and Distribution Agreement to effect the separation and provide a framework for our relationship with Straight Path after the spin-off, and a Tax Separation Agreement, which sets forth the responsibilities of us and Straight Path with respect to, among other things, liabilities for federal, state, local and foreign taxes for periods before and including the spin-off, the preparation and filing of tax returns for such periods and disputes with taxing authorities regarding taxes for such periods. Pursuant to the Separation and Distribution Agreement, we indemnify Straight Path and Straight Path indemnifies us for losses related to the failure of the other to pay, perform or otherwise discharge, any of the liabilities and obligations set forth in the agreement. Pursuant to the Tax Separation Agreement, we indemnify Straight Path from all liability for taxes of Straight Path or any of its subsidiaries or relating to the Straight Path business with respect to taxable periods ending on or before the spin-off, from all liability for taxes of ours, other than Straight Path and its subsidiaries, for any taxable period, and from all liability for taxes due to the spin-off. (See Note 11 to the Consolidated Financial Statements included in Item 1 to Part I of the Quarterly Report on Form 10-Q).

In connection with our spin-off of Zedge, Inc., or Zedge, in June 2016, we and Zedge entered into various agreements prior to the spin-off including a Separation and Distribution Agreement to effect the separation and provide a framework for our relationship with Zedge after the spin-off, and a Tax Separation Agreement, which sets forth the responsibilities of us and Zedge with respect to, among other things, liabilities for federal, state, local and foreign taxes for periods before and including the spin-off, the preparation and filing of tax returns for such periods and disputes with taxing authorities regarding taxes for such periods. Pursuant to Separation and Distribution Agreement, among other things, we indemnify Zedge and Zedge indemnifies us for losses related to the failure of the other to pay, perform or otherwise discharge, any of the liabilities and obligations set forth in the agreement. Pursuant to the Tax Separation Agreement, among other things, Zedge indemnifies us from all liability for taxes of Zedge and any of Zedge’s subsidiaries or relating to Zedge’s business accruing after the spin-off, and we indemnify Zedge from all liability for taxes of Zedge and any of Zedge’s subsidiaries or relating to Zedge’s business with respect to taxable periods ending on or before the spin-off.

IDT Payment Services and IDT Telecom have performance bonds issued through third parties for the benefit of various states in order to comply with the states’ financial requirements for money remittance licenses and telecommunications resellers, respectively. At January 31, 2018, we had aggregate performance bonds of $15.1 million outstanding.

30

Item 3. Quantitative and Qualitative Disclosures About Market Risks

Foreign Currency Risk

Revenues from our international operations were 32% and 31% of our consolidated revenues for the six months ended January 31, 2018 and 2017, respectively. A significant portion of these revenues is in currencies other than the U.S. Dollar. Our foreign currency exchange risk is somewhat mitigated by our ability to offset a portion of these non-U.S. Dollar-denominated revenues with operating expenses that are paid in the same currencies. While the impact from fluctuations in foreign exchange rates affects our revenue and expenses denominated in foreign currencies, the net amount of our exposure to foreign currency exchange rate changes at the end of each reporting period is generally not material.

Investment Risk

In addition to, but separate from our primary business, we hold a portion of our assets in marketable securities and hedge funds for strategic and speculative purposes. At January 31, 2018, the carrying value of our marketable securities and investments in hedge funds was $46.2 million and $8.8 million, respectively. Investments in marketable securities and hedge funds carry a degree of risk, and depend to a great extent on correct assessments of the future course of price movements of securities and other instruments. There can be no assurance that our investment managers will be able to accurately predict these price movements. The securities markets have in recent years been characterized by great volatility and unpredictability. Accordingly, the value of our investments may go down as well as up and we may not receive the amounts originally invested upon redemption.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures. Our Chief Executive Officer and Principal Financial Officer have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our Chief Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures were effective as of January 31, 2018.

Changes in Internal Control over Financial Reporting. There were no changes in our internal control over financial reporting during the quarter ended January 31, 2018 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

31

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

Legal proceedings in which we are involved are more fully described in Note 11 to the Consolidated Financial Statements included in Item 1 to Part I of this Quarterly Report on Form 10-Q.

Item 1A. Risk Factors

There are no material changes from the risk factors previously disclosed in Item 1A to Part I of our Annual Report on Form 10-K for the year ended July 31, 2017.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information with respect to purchases by us of our shares during the second quarter of fiscal 2018:

	Total Number of Shares Purchased		Average Price per Share		Total Number of Shares Purchased as part of Publicly Announced Plans or Programs		Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs (1)
November 1-30, 2017		—	$	—		—		8,000,000
December 1-31, 2017		—	$	—		—		8,000,000
January 1–31, 2018 (2)		3,502	$	10.77		—		8,000,000
Total		3,502	$	10.77		—

(1) On January 22, 2016, our Board of Directors approved a stock repurchase program to purchase up to 8.0 million shares of our Class B common stock and cancelled the previous stock repurchase program originally approved by the Board of Directors on June 13, 2006, which had 4,636,741 shares remaining available for repurchase.

(2) Consists of shares of Class B common stock that were tendered by employees of ours to satisfy the employees’ tax withholding obligations in connection with the lapsing of restrictions on awards of restricted stock. Such shares were repurchased by us based on their fair market value on the trading day immediately prior to the vesting date and the proceeds utilized to pay the taxes due upon such vesting event.

Item 3. Defaults Upon Senior Securities

None

Item 4. Mine Safety Disclosures

Not applicable

Item 5. Other Information

None

32

Item 6. Exhibits

Exhibit Number	Description
31.1*	Certification of Chief Executive Officer pursuant to 17 CFR 240.13a-14(a), as adopted pursuant to §302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Principal Financial Officer pursuant to 17 CFR 240.13a-14(a), as adopted pursuant to §302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002.
32.2*	Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002.
101.INS*	XBRL Instance Document
101.SCH*	XBRL Taxonomy Extension Schema Document
101.CAL*	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*	XBRL Taxonomy Extension Label Linkbase Document
101.PRE*	XBRL Taxonomy Extension Presentation Linkbase Document

* Filed or furnished herewith.

33

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	IDT CORPORATION
March 12, 2018	By:	/s/    Shmuel Jonas
		Shmuel Jonas Chief Executive Officer
March 12, 2018	By:	/s/    Marcelo Fischer
		Marcelo Fischer Senior Vice President of Finance (Principal Financial Officer)

34

EX-31.1

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a)
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Shmuel Jonas, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of IDT Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 12, 2018

/s/    Shmuel Jonas        

Shmuel Jonas

Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a)
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Marcelo Fischer, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of IDT Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 12, 2018

/s/    Marcelo Fischer

Marcelo Fischer

Senior Vice President of Finance

(Principal Financial Officer)

EX-32.1

EXHIBIT 32.1

Certification Pursuant to
18 U.S.C. Section 1350
(as Adopted Pursuant to Section 906 of
the Sarbanes-Oxley Act Of 2002)

In connection with the Quarterly Report of IDT Corporation (the “Company”) on Form 10-Q for the quarter ended January 31, 2018 as filed with the Securities and Exchange Commission (the “Report”), I, Shmuel Jonas, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 12, 2018

/s/    Shmuel Jonas        

Shmuel Jonas

Chief Executive Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to IDT Corporation and will be retained by IDT Corporation and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

EXHIBIT 32.2

Certification Pursuant to
18 U.S.C. Section 1350
(as Adopted Pursuant to Section 906 of
the Sarbanes-Oxley Act Of 2002)

In connection with the Quarterly Report of IDT Corporation (the “Company”) on Form 10-Q for the quarter ended January 31, 2018 as filed with the Securities and Exchange Commission (the “Report”), I, Marcelo Fischer, Senior Vice President of Finance of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 12, 2018

/s/    Marcelo Fischer

Marcelo Fischer

Senior Vice President of Finance

(Principal Financial Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to IDT Corporation and will be retained by IDT Corporation and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	6 Months Ended
	Jan. 31, 2018	Mar. 08, 2018
Entity Registrant Name	IDT CORP
Entity Central Index Key	0001005731
Amendment Flag	false
Trading Symbol	IDT
Current Fiscal Year End Date	--07-31
Document Type	10-Q
Document Period End Date	Jan. 31, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q2
Entity Filer Category	Accelerated Filer
Class A Common Stock
Entity Common Stock Shares Outstanding		1,574,326
Class B Common Stock
Entity Common Stock Shares Outstanding		23,279,953

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Jan. 31, 2018	Jul. 31, 2017
Current assets:
Cash and cash equivalents	$ 54,055	$ 90,344
Marketable securities	46,202	58,272
Trade accounts receivable, net of allowance for doubtful accounts of $2,642 at January 31, 2018 and $2,657 at July 31, 2017	71,652	64,979
Prepaid expenses	15,915	14,506
Other current assets	30,733	18,749
Assets held for sale	138,700	124,267
Total current assets	357,257	371,117
Property, plant and equipment, net	88,621	88,994
Goodwill	11,447	11,326
Investments	24,350	26,894
Deferred income tax assets, net	8,653	11,841
Other assets	8,616	3,657
Assets held for sale	5,285	5,134
Total assets	504,229	518,963
Current liabilities:
Trade accounts payable	37,071	40,989
Accrued expenses	113,154	125,359
Deferred revenue	71,789	76,451
Other current liabilities	4,683	4,659
Liabilities held for sale	129,423	115,318
Total current liabilities	356,120	362,776
Other liabilities	1,107	1,080
Liabilities held for sale	642	550
Total liabilities	357,869	364,406
Commitments and contingencies
IDT Corporation stockholders' equity:
Preferred stock, $.01 par value; authorized shares-10,000; no shares issued
Additional paid-in capital	396,259	394,462
Treasury stock, at cost, consisting of 1,698 and 1,698 shares of Class A common stock and 2,302 and 2,297 shares of Class B common stock at January 31, 2018 and July 31, 2017, respectively	(83,365)	(83,304)
Accumulated other comprehensive loss	(2,531)	(2,343)
Accumulated deficit	(173,386)	(163,370)
Total IDT Corporation stockholders' equity	137,266	145,734
Noncontrolling interests	9,094	8,823
Total equity	146,360	154,557
Total liabilities and equity	504,229	518,963
Class A Common Stock
IDT Corporation stockholders' equity:
Common stock, value	33	33
Class B Common Stock
IDT Corporation stockholders' equity:
Common stock, value	$ 256	$ 256

XML

Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Jan. 31, 2018	Jul. 31, 2017
Allowance for doubtful accounts	$ 2,642	$ 2,657
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized shares	10,000	10,000
Preferred stock, shares issued
Class A Common Stock
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	35,000	35,000
Common stock, shares issued	3,272	3,272
Common stock, shares outstanding	1,574	1,574
Treasury stock, common stock shares	1,698	1,698
Class B Common Stock
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	200,000	200,000
Common stock, shares issued	25,582	25,561
Common stock, shares outstanding	23,280	23,264
Treasury stock, common stock shares	2,302	2,297

XML

Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		6 Months Ended
		Jan. 31, 2018	Jan. 31, 2017	Jan. 31, 2018	Jan. 31, 2017
Consolidated Statements of Operations [Abstract]
Revenues		$ 395,883	$ 367,556	$ 789,438	$ 736,707
Costs and expenses:
Direct cost of revenues (exclusive of depreciation and amortization)		337,229	310,913	673,738	623,941
Selling, general and administrative	[1]	52,358	47,325	102,429	92,763
Depreciation and amortization		5,735	5,301	11,408	10,601
Severance		195		635
Total costs and expenses		395,517	363,539	788,210	727,305
Other operating expense		(846)	(889)	(1,625)	(1,088)
(Loss) income from operations		(480)	3,128	(397)	8,314
Interest income, net		286	309	648	609
Other income (expense), net		370	(419)	(456)	1,974
Income (loss) before income taxes		176	3,018	(205)	10,897
Benefit from (provision for) income taxes		1,514	(1,761)	99	12,655
Net income (loss)		1,690	1,257	(106)	23,552
Net income attributable to noncontrolling interests		(174)	(382)	(470)	(758)
Net income (loss) attributable to IDT Corporation		$ 1,516	$ 875	$ (576)	$ 22,794
Earnings (loss) per share attributable to IDT Corporation common stockholders:
Basic		$ 0.06	$ 0.04	$ (0.02)	$ 1
Diluted		$ 0.06	$ 0.04	$ (0.02)	$ 0.99
Weighted-average number of shares used in calculation of earnings (loss) per share:
Basic		24,643	22,768	24,635	22,740
Diluted		24,724	22,963	24,635	22,931
Dividends declared per common share		$ 0.19	$ 0.19	$ 0.38	$ 0.38
(i) Stock-based compensation included in selling, general and administrative expenses		$ 987	$ 1,426	$ 1,797	$ 2,128

[1] Stock-based compensation included in selling, general and administrative expenses

XML

Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2018	Jan. 31, 2017	Jan. 31, 2018	Jan. 31, 2017
Consolidated Statements of Comprehensive Income [Abstract]
Net (loss) income	$ 1,690	$ 1,257	$ (106)	$ 23,552
Other comprehensive income (loss):
Change in unrealized loss on available-for-sale securities	(120)	(40)	(150)	(63)
Foreign currency translation adjustments	330	459	(38)	(2,403)
Other comprehensive income (loss)	210	419	(188)	(2,466)
Comprehensive income (loss)	1,900	1,676	(294)	21,086
Comprehensive income attributable to noncontrolling interests	(174)	(382)	(470)	(758)
Comprehensive income (loss) attributable to IDT Corporation	$ 1,726	$ 1,294	$ (764)	$ 20,328

XML

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jan. 31, 2018	Jan. 31, 2017
Operating activities
Net (loss) income	$ (106)	$ 23,552
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization	11,408	10,601
Deferred income taxes	3,212	(12,868)
Provision for doubtful accounts receivable	696	126
Realized loss (gain) on marketable securities	9	(305)
Interest in the equity of investments	(77)	(295)
Stock-based compensation	1,797	2,128
Change in assets and liabilities:
Restricted cash and cash equivalents	(3,663)	4,098
Trade accounts receivable	(4,568)	(8,189)
Prepaid expenses, other current assets and other assets	(15,109)	(1,432)
Trade accounts payable, accrued expenses, other current liabilities and other liabilities	(20,344)	(15,010)
Customer deposits	4,481	(1,177)
Deferred revenue	(4,710)	(2,043)
Net cash used in operating activities	(26,974)	(814)
Investing activities
Capital expenditures	(10,931)	(10,543)
Proceeds from sale of interest in Straight Path IP Group Holding, Inc.	6,000
Purchase of IP Interest from Straight Path Communications Inc.	(6,000)
Payment for acquisition, net of cash acquired		(1,827)
Cash used for investments		(8,304)
Purchases of marketable securities	(19,797)	(17,209)
Proceeds from maturities and sales of marketable securities	31,610	16,848
Net cash provided by (used in) investing activities	882	(21,035)
Financing activities
Dividends paid	(9,440)	(8,765)
Distributions to noncontrolling interests	(717)	(817)
Proceeds from borrowings under revolving credit facility	19,080
Repayments of borrowings under revolving credit facility	(19,080)
Proceeds from exercise of stock options		835
Proceeds from sale of member interests in CS Pharma Holdings, LLC.		1,250
Repurchases of Class B common stock	(61)	(1,838)
Net cash used in financing activities	(10,218)	(9,335)
Effect of exchange rate changes on cash and cash equivalents	592	(829)
Net decrease in cash and cash equivalents	(35,718)	(32,013)
Cash and cash equivalents at beginning of period, including $5,716 held for sale at July 31, 2017	96,060	109,537
Cash and cash equivalents at end of period, including $6,287 held for sale at January 31, 2018	60,342	77,524
Supplemental schedule of non-cash investing and financing activities
Reclassification of liability for member interests in CS Pharma Holdings, LLC		$ 8,750

XML

Consolidated Statements of Cash Flows (Parenthetical) (Unaudited) - USD ($) $ in Thousands	Jan. 31, 2018	Jul. 31, 2017
Consolidated Statements of Cash Flows [Abstract]
Cash and cash equivalents	$ 6,287	$ 5,716

XML

Basis of Presentation

6 Months Ended

Jan. 31, 2018

Basis of Presentation [Abstract]

Basis of Presentation

Note 1—Basis of Presentation

The accompanying unaudited consolidated financial statements of IDT Corporation and its subsidiaries (the “Company” or “IDT”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six months ended January 31, 2018 are not necessarily indicative of the results that may be expected for the fiscal year ending July 31, 2018. The balance sheet at July 31, 2017 has been derived from the Company’s audited financial statements at that date but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. For further information, please refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended July 31, 2017, as filed with the U.S. Securities and Exchange Commission (“SEC”).

The Company’s fiscal year ends on July 31 of each calendar year. Each reference below to a fiscal year refers to the fiscal year ending in the calendar year indicated (e.g., fiscal 2018 refers to the fiscal year ending July 31, 2018).

XML

IDT Financial Services Holding Limited Assets and Liabilities Held for Sale

6 Months Ended

Jan. 31, 2018

IDT Financial Services Holding Limited Assets and Liabilities Held for Sale [Abstract]

IDT Financial Services Holding Limited Assets and Liabilities Held for Sale

Note 2— IDT Financial Services Holding Limited Assets and Liabilities Held for Sale

On June 22, 2017, the Company’s wholly-owned subsidiary IDT Telecom, Inc. (“IDT Telecom”) entered into a Share Purchase Agreement with JAR Fintech Limited (“JAR Fintech”) and JAR Capital Limited to sell the capital stock of IDT Financial Services Holding Limited, a company incorporated under the laws of Gibraltar and a wholly-owned subsidiary of IDT Telecom (“IDTFS Holding”), to JAR Fintech. IDTFS Holding is the sole shareholder of IDT Financial Services Limited (“IDTFS”), a Gibraltar-based bank and e-money issuer, providing prepaid card solutions across the European Economic Area. The Share Purchase Agreement provides for an aggregate purchase price for the outstanding equity interests of IDTFS Holding of approximately $4.1 million plus an amount equal to the value of IDTFS’ net assets, to be paid at closing, subject to adjustments relating to customer assets of IDTFS. The net asset value of IDTFS was $14.5 million at January 31, 2018. A portion of the purchase price will be placed in escrow at closing and released to IDT Telecom once all of the conditions have been met under the Share Purchase Agreement. The sale is expected to close in the second quarter of calendar 2018, subject to regulatory approval and other customary conditions set forth in the Share Purchase Agreement. The remaining closing conditions are outside of the Company’s control and there can be no assurance that the sale will be completed.

The pending disposition of IDTFS Holding did not meet the criteria to be reported as a discontinued operation and accordingly, its results of operations and cash flows have not been reclassified. The IDTFS Holding assets and liabilities held for sale included the following:

	January 31, 2018		July 31, 2017
	(in thousands)
Current assets held for sale:
Cash and cash equivalents	$	6,287	$	5,716
Restricted cash and cash equivalents		128,153		115,609
Trade accounts receivable, net of allowance for doubtful accounts of $3,239 and $2,550 at January 31, 2018 and July 31, 2017, respectively		2,919		1,844
Prepaid expenses		854		758
Other current assets		487		340
Total current assets held for sale	$	138,700	$	124,267
Noncurrent assets held for sale:
Property, plant and equipment, net	$	19	$	24
Other intangibles, net		164		165
Other assets		5,102		4,945
Total noncurrent assets held for sale	$	5,285	$	5,134
Current liabilities held for sale:
Trade accounts payable	$	2,007	$	372
Accrued expenses		252		226
Customer deposits		127,107		114,689
Other current liabilities		57		31
Total current liabilities held for sale	$	129,423	$	115,318
Noncurrent liabilities held for sale:
Other liabilities	$	642	$	550
Total noncurrent liabilities held for sale	$	642	$	550

IDTFS Holding is included in the Telecom Platform Services segment. IDTFS Holding’s (loss) income before income taxes and (loss) income before income taxes attributable to the Company, which is included in the accompanying consolidated statements of operations, were as follows:

	Three Months Ended January 31,						Six Months Ended January 31,
	2018			2017			2018			2017
	(in thousands)
(Loss) income before income taxes	$	(559	)	$	(421	)	$	(1,009	)	$	174
(Loss) income before income taxes attributable to IDT Corporation	$	(559	)	$	(421	)	$	(1,009	)	$	174

XML

Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc.

6 Months Ended

Jan. 31, 2018

Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc. [Abstract]

Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc.

Note 3—Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc.

On or about March 26, 2018, the Company expects to spin-off its subsidiary, Rafael Holdings, Inc. (“RHI”), to the Company’s stockholders, so that RHI will be a separate publicly traded company. Approval of the spin-off by the Company’s stockholders is not required. The Company’s Board of Directors believes that the spin-off will allow RHI to better focus on its strategic mission and that its potential can be better realized as an independent entity. The spin-off of RHI will occur by way of a pro rata distribution of RHI’s capital stock to the Company’s stockholders. On the distribution date, each of the Company’s stockholders as of the record date for the distribution of March 13, 2018 will receive one share of RHI Class A common stock for every two shares of the Company’s Class A common stock and one share of RHI Class B common stock for every two shares of the Company’s Class B common stock. Completion of the RHI spin-off is subject to receipt of a favorable opinion as to the spin-off’s tax-free status.

RHI owns the commercial real estate assets held by the Company and interests in two clinical stage pharmaceutical companies. The commercial real estate holdings consist of the Company’s headquarters building and its associated public garage in Newark, New Jersey, an office/data center building in Piscataway, New Jersey and a portion of a building in Israel that hosts offices for the Company and certain affiliates. The pharmaceutical holdings include debt interests and warrants in Rafael Pharmaceuticals, Inc. (“Rafael Pharma”), which is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells, and a majority equity interest in Lipomedix Pharmaceuticals Ltd., a pharmaceutical development company based in Israel. In addition, prior to the spin-off, the Company intends to transfer assets to RHI such that, at the time of the spin-off, RHI will have approximately $44 million in cash, cash equivalents, and marketable securities, plus $6 million in hedge fund and other investments.

RHI’s interests in Rafael Pharma, which are held through a 90%-owned non-operating subsidiary, IDT-Rafael Holdings, LLC (“IDT-Rafael Holdings”), include convertible notes issued by Rafael Pharma, and a warrant held by the Company and certain minority holders to purchase up to a majority equity stake in Rafael Pharma at the Company’s discretion in accordance with the terms of the convertible note and the warrant. The remaining 10% of IDT-Rafael Holdings is held by Howard S. Jonas, the Company’s Chairman of the Board, and Chairman of the Board of Rafael Pharma.

IDT-Rafael Holdings had the contractual right to receive additional shares of Rafael Pharma representing 10% of the outstanding capital stock of Rafael Pharma that will be issued upon the occurrence of any of the following: (i) Food and Drug Administration approval of a Rafael Pharma drug application, (ii) an initial public offering of Rafael Pharma at a valuation of over $500 million, or (iii) a sale of Rafael Pharma above certain valuations. Currently, none of the conditions have been satisfied and the right remains contingent. On September 14, 2017, IDT-Rafael Holdings distributed this right to its members on a pro rata basis such that the Company received the right to 9% of the outstanding capital stock of Rafael Pharma and Howard Jonas received the right to 1% of the outstanding capital stock of Rafael Pharma. In addition, as compensation for assuming the role of Chairman of the Board of Rafael Pharma, and to create additional incentive to contribute to the success of Rafael Pharma, on September 19, 2017, the Company transferred its right to receive 9% of the outstanding capital stock of Rafael Pharma to Mr. Jonas. The right is further transferable at the discretion of Mr. Jonas.

Howard Jonas and his wife Deborah Jonas jointly own $525,000 of Series C Convertible Notes of Rafael Pharma, and The Howard S. and Deborah Jonas Foundation own an additional $525,000 of Series C Convertible Notes of Rafael Pharma. 

IDT-Rafael Holdings’ controlled 50%-owned subsidiary, CS Pharma Holdings, LLC (“CS Pharma”), holds Rafael Pharma’s Series D convertible promissory note with a principal amount of $10 million (the “Series D Note”). The Series D Note earns interest at 3.5% per annum, with principal and accrued interest due and payable on September 16, 2018. The Series D Note is convertible at the holder’s option into shares of Rafael Pharma’s Series D Preferred Stock. The Series D Note also includes a mandatory conversion into Rafael Pharma common stock upon a qualified initial public offering, and conversion at the holder’s option upon an unqualified financing event. In all cases, the Series D Note conversion price is based on the applicable financing purchase price.

IDT-Rafael Holdings and CS Pharma hold warrants to purchase shares of capital stock of Rafael Pharma representing in the aggregate up to 56% of the then issued and outstanding capital stock of Rafael Pharma, on an as-converted and fully diluted basis. The right to exercise warrants as to the first $10 million thereof is held by CS Pharma. The exercise price of the warrant is the lower of 70% of the price sold in an equity financing, or $1.25 per share, subject to certain adjustments. The minimum initial and subsequent exercises of the warrant shall be for such number of shares that will result in at least $5 million of gross proceeds to Rafael Pharma, or such lesser amount as represents 5% of the outstanding capital stock of Rafael Pharma, or such lesser amount as may then remain unexercised. The warrant will expire upon the earlier of December 31, 2020 or a qualified initial public offering or liquidation event. 

The Company’s investment in Rafael Pharma, which was included in “Investments” in the accompanying consolidated balance sheets, consists of the following:

	January 31, 2018		July 31, 2017
	(in thousands)
Series D Note (at fair value)	$	6,300	$	6,300
Warrants (at cost)		5,400		5,400
Right to receive additional shares (at cost)		—		400
Total investment in Rafael Pharma	$	11,700	$	12,100

Rafael Pharma is a variable interest entity, however, the Company has determined that it is not the primary beneficiary as the Company does not have the power to direct the activities of Rafael Pharma that most significantly impact Rafael Pharma’s economic performance. At January 31, 2018, the Company’s maximum exposure to loss as a result of its involvement with Rafael Pharma was its $11.7 million investment, since there were no other arrangements, events or circumstances that could expose the Company to additional loss.

XML

Marketable Securities

6 Months Ended

Jan. 31, 2018

Marketable Securities [Abstract]

Marketable Securities

Note 4—Marketable Securities

The following is a summary of marketable securities:

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
	(in thousands)
Available-for-sale securities:
January 31, 2018:
Certificates of deposit*	$	24,441	$	2	$	(1	)	$	24,442
Federal Government Sponsored Enterprise notes		3,216		—		(26	)		3,190
International agency notes		399		—		(9	)		390
Mutual funds		5,425		40		—			5,465
Corporate bonds		3,332		—		(39	)		3,293
Equity		79		—		(3	)		76
U.S. Treasury notes		5,397		—		(76	)		5,321
Municipal bonds		4,029		—		(4	)		4,025
Total	$	46,318	$	42	$	(158	)	$	46,202
July 31, 2017:
Certificates of deposit*	$	29,011	$	1	$	(7	)	$	29,005
Federal Government Sponsored Enterprise notes		3,992		—		(14	)		3,978
International agency notes		291		—		—			291
Mutual funds		5,353		77		—			5,430
Corporate bonds		4,643		—		—			4,643
Equity		74		—		(26	)		48
U.S. Treasury notes		6,673		—		—			6,673
Municipal bonds		8,201		4		(1	)		8,204
Total	$	58,238	$	82	$	(48	)	$	58,272

* Each of the Company’s certificates of deposit has a CUSIP, was purchased in the secondary market through a broker, and may be sold in the secondary market.

At January 31, 2018 and July 31, 2017, the Company owned 24,923 and 23,227 shares, respectively, of Zedge, Inc. Class B common stock that had a fair value of $76,000 and $48,000, respectively.

Proceeds from maturities and sales of available-for-sale securities were $12.1 million and $10.8 million in the three months ended January 31, 2018 and 2017, respectively, and $31.6 million and $16.8 million in the six months ended January 31, 2018 and 2017, respectively. The gross realized losses that were included in earnings as a result of sales were $16,000 and $9,000 in the three and six months ended January 31, 2018, respectively. The gross realized gains that were included in earnings as a result of sales were $0.3 million in the three and six months ended January 31, 2017. The Company uses the specific identification method in computing the gross realized gains and gross realized losses on the sales of marketable securities.

The contractual maturities of the Company’s available-for-sale debt securities at January 31, 2018 were as follows:

	Fair Value
	(in thousands)
Within one year	$	25,771
After one year through five years		14,890
After five years through ten years		—
After ten years		—
Total	$	40,661

The following available-for-sale securities were in an unrealized loss position for which other-than-temporary impairments have not been recognized:

	Unrealized Losses		Fair Value
	(in thousands)
January 31, 2018:
Certificates of deposit	$	1	$	5,340
Federal Government Sponsored Enterprise notes		26		3,190
International agency notes		9		390
Corporate bonds		39		3,293
Equity		3		76
U.S. Treasury notes		76		5,321
Municipal bonds		4		3,067
Total	$	158	$	20,677
July 31, 2017:
Certificates of deposit	$	7	$	12,155
Federal Government Sponsored Enterprise notes		14		3,529
Equity		26		48
Municipal bonds		1		3,349
Total	$	48	$	19,081

At July 31, 2017, there were no securities in a continuous unrealized loss position for 12 months or longer. At January 31, 2018, the following available-for-sale securities included in the table above were in a continuous unrealized loss position for 12 months or longer:

	Unrealized Losses		Fair Value
	(in thousands)
Federal Government Sponsored Enterprise notes	$	13	$	1,810
Municipal bonds		1		348
Total	$	14	$	2,158

At January 31, 2018, the Company did not intend to sell the securities that were in a continuous unrealized loss position for 12 months or longer, and it is not more likely than not that the Company will be required to sell the securities before recovery of their amortized cost bases, which may be at maturity.

XML

Fair Value Measurements

6 Months Ended

Jan. 31, 2018

Fair Value Measurements [Abstract]

Fair Value Measurements

Note 5—Fair Value Measurements

The following tables present the balance of assets measured at fair value on a recurring basis:

	Level 1 (1)		Level 2 (2)		Level 3 (3)		Total
	(in thousands)
January 31, 2018
Available-for-sale securities:
Marketable securities	$	10,862	$	35,340	$	—	$	46,202
Rafael Pharma Series D Note		—		—		6,300		6,300
Total	$	10,862	$	35,340	$	6,300	$	52,502
July 31, 2017
Available-for-sale securities:
Marketable securities	$	12,151	$	46,121	$	—	$	58,272
Rafael Pharma Series D Note		—		—		6,300		6,300
Total	$	12,151	$	46,121	$	6,300	$	64,572

(1) – quoted prices in active markets for identical assets or liabilities

(2) – observable inputs other than quoted prices in active markets for identical assets and liabilities

(3) – no observable pricing inputs in the market

At January 31, 2018 and July 31, 2017, the Company did not have any liabilities measured at fair value on a recurring basis.

At January 31, 2018 and July 31, 2017, the fair value of the Rafael Pharma Series D Note, which was classified as Level 3, was estimated based on a valuation of Rafael Pharma and other factors that could not be corroborated by the market.

The following table summarizes the change in the balance of the Company’s assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3). There were no liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) in the three and six months ended January 31, 2018 and 2017.

	Three Months Ended January 31,				Six Months Ended January 31,
	2018		2017		2018		2017
	(in thousands)
Balance, beginning of period	$	6,300	$	4,200	$	6,300	$	2,000
Purchases		—		—		—		2,200
Balance, end of period	$	6,300	$	4,200	$	6,300	$	4,200
Change in unrealized gains or losses for the period included in earnings for assets held at the end of the period	$	—	$	—	$	—	$	—

At January 31, 2018 and July 31, 2017, the Company had $8.8 million and $8.6 million, respectively, in investments in hedge funds, which were included in “Investments” in the accompanying consolidated balance sheets. The Company’s investments in hedge funds are accounted for using the equity method or the cost method, therefore investments in hedge funds are not measured at fair value.

Fair Value of Other Financial Instruments

The estimated fair value of the Company’s other financial instruments was determined using available market information or other appropriate valuation methodologies. However, considerable judgment is required in interpreting these data to develop estimates of fair value. Consequently, the estimates are not necessarily indicative of the amounts that could be realized or would be paid in a current market exchange.

Cash and cash equivalents, restricted cash and cash equivalents, other current assets, customer deposits and other current liabilities. At January 31, 2018 and July 31, 2017, the carrying amount of these assets and liabilities approximated fair value because of the short period of time to maturity. The fair value estimates for cash, cash equivalents and restricted cash and cash equivalents were classified as Level 1 and other current assets, customer deposits and other current liabilities were classified as Level 2 of the fair value hierarchy.

Other assets and other liabilities. At January 31, 2018 and July 31, 2017, the carrying amount of these assets and liabilities approximated fair value. The fair values were estimated based on the Company’s assumptions, which were classified as Level 3 of the fair value hierarchy.

The Company’s investments at January 31, 2018 and July 31, 2017 included investments in the equity of certain privately held entities and other investments that are accounted for at cost. It is not practicable to estimate the fair value of these investments because of the lack of a quoted market price for the shares of these entities, and the inability to estimate their fair value without incurring excessive cost. The carrying value of these investments was $10.4 million and $10.8 million at January 31, 2018 and July 31, 2017, respectively, which the Company believes was not impaired.

XML

Equity

6 Months Ended

Jan. 31, 2018

Equity [Abstract]

Equity

Note 6— Equity

Changes in the components of equity were as follows:

	Six Months Ended  January 31, 2018
	Attributable to IDT Corporation			Noncontrolling Interests			Total
	(in thousands)
Balance, July 31, 2017	$	145,734		$	8,823		$	154,557
Dividends declared ($0.38 per share)		(9,440	)		—			(9,440	)
Restricted Class B common stock purchased from employees		(61	)		—			(61	)
Transfer of right to receive equity to Howard S. Jonas		—			(40	)		(40	)
Consolidation of Lipomedix Pharmaceuticals Ltd.		—			558			558
Distributions to noncontrolling interests		—			(717	)		(717	)
Stock-based compensation		1,797			—			1,797
Comprehensive income:
Net loss		(576	)		470			(106	)
Other comprehensive loss		(188	)		—			(188	)
Comprehensive income		(764	)		470			(294	)
Balance, January 31, 2018	$	137,266		$	9,094		$	146,360

Dividend Payments

In the six months ended January 31, 2018, the Company paid cash dividends of $0.38 per share on its Class A common stock and Class B common stock, or $9.4 million in total. In the six months ended October 31, 2016, the Company paid cash dividends of $0.38 per share on its Class A common stock and Class B common stock, or $8.8 million in total.

On March 5, 2018, the Company’s Board of Directors declared a dividend of $0.09 per share for the second quarter of fiscal 2018 to holders of the Company’s Class A common stock and Class B common stock. The dividend will be paid on or about March 23, 2018 to stockholders of record as of the close of business on March 19, 2018.

Stock Repurchases

The Company has a stock repurchase program for the repurchase of up to an aggregate of 8.0 million shares of the Company’s Class B common stock. There were no repurchases under the program in the six months ended January 31, 2018 or 2017. At January 31, 2018, 8.0 million shares remained available for repurchase under the stock repurchase program.

In the six months ended January 31, 2018 and 2017, the Company paid $0.1 million and $1.8 million, respectively, to repurchase 5,170 shares and 94,338 shares, respectively, of Class B common stock that were tendered by employees of the Company to satisfy the employees’ tax withholding obligations in connection with the lapsing of restrictions on awards of restricted stock. Such shares were repurchased by the Company based on their fair market value on the trading day immediately prior to the vesting date.

2015 Stock Option and Incentive Plan

On December 14, 2017, the Company’s stockholders approved an amendment to the Company’s 2015 Stock Option and Incentive Plan to increase the number of shares of the Company’s Class B common stock available for the grant of awards thereunder by an additional 0.3 million shares.

In the six months ended January 31, 2017, the Company received proceeds from the exercise of its stock options of $0.8 million. There were no stock option exercises in the six months ended January 31, 2018. In the six months ended January 31, 2017, the Company issued 73,471 shares of its Class B common stock for the stock option exercises.

XML

Earnings (Loss) Per Share

6 Months Ended

Jan. 31, 2018

(Loss) Earnings Per Share [Abstract]

(Loss) Earnings Per Share

Note 7— Earnings (Loss) Per Share

Basic earnings per share is computed by dividing net income attributable to all classes of common stockholders of the Company by the weighted average number of shares of all classes of common stock outstanding during the applicable period. Diluted earnings per share is computed in the same manner as basic earnings per share, except that the number of shares is increased to include restricted stock still subject to risk of forfeiture and to assume exercise of potentially dilutive stock options using the treasury stock method, unless the effect of such increase is anti-dilutive.

The weighted-average number of shares used in the calculation of basic and diluted earnings (loss) per share attributable to the Company’s common stockholders consists of the following:

	Three Months Ended January 31,				Six Months Ended January 31,
	2018		2017		2018		2017
	(in thousands)
Basic weighted-average number of shares		24,643		22,768		24,635		22,740
Effect of dilutive securities:
Stock options		10		77		—		58
Non-vested restricted Class B common stock		71		118		—		133
Diluted weighted-average number of shares		24,724		22,963		24,635		22,931

The following shares were excluded from the diluted earnings per share computation:

	Three Months Ended January 31,				Six Months Ended January 31,
	2018		2017		2018		2017
	(in thousands)
Stock options		1,160		3		1,273		18
Non-vested restricted Class B common stock		—		—		191		—
Shares excluded from the calculation of diluted earnings per share		1,160		3		1,464		18

In the three months ended January 31, 2018, and in the three and six months ended January 31, 2017, stock options with an exercise price that was greater than the average market price of the Company’s stock during the period were excluded from the diluted earnings per share computation.

In the six months ended January 31, 2018, the diluted loss per share computation equals basic loss per share because the Company had a net loss and the impact of the assumed exercise of stock options and the vesting of restricted stock would have been anti-dilutive.

XML

Revolving Credit Facility

6 Months Ended

Jan. 31, 2018

Revolving Credit Facility [Abstract]

Revolving Credit Facility

Note 8—Revolving Credit Facility

The Company’s subsidiary, IDT Telecom, entered into a credit agreement, dated July 12, 2012, with TD Bank, N.A. for a line of credit facility for up to a maximum principal amount of $25.0 million. The credit agreement was amended as of January 31, 2018. IDT Telecom may use the proceeds to finance working capital requirements, acquisitions and for other general corporate purposes. The line of credit facility is secured by primarily all of IDT Telecom’s assets. The principal outstanding bears interest per annum, at the option of IDT Telecom, at either (a) the U.S. Prime Rate less 125 basis points, or (b) the LIBOR rate adjusted by the Regulation D maximum reserve requirement plus 125 basis points. Interest is payable monthly and all outstanding principal and any accrued and unpaid interest is due on the maturity date of January 31, 2020. At January 31, 2018 and July 31, 2017, there were no amounts outstanding under the facility. The Company intends to borrow under the facility from time to time. IDT Telecom pays a quarterly unused commitment fee of 0.325% per annum on the average daily balance of the unused portion of the $25.0 million commitment. IDT Telecom is required to comply with various affirmative and negative covenants as well as maintain certain financial targets and ratios during the term of the line of credit, including restrictions on dividend payments on IDT Telecom capital stock and restrictions on IDT Telecom’s aggregate loans and advances to affiliates or subsidiaries.

XML

Accumulated Other Comprehensive Loss

6 Months Ended

Jan. 31, 2018

Accumulated Other Comprehensive Loss [Abstract]

Accumulated Other Comprehensive Loss

Note 9—Accumulated Other Comprehensive Loss

The accumulated balances for each classification of other comprehensive loss were as follows:

	Unrealized Gain (Loss) on Available-for-Sale Securities			Foreign Currency Translation			Accumulated Other Comprehensive Loss			Location of (Gain) Loss Recognized
	(in thousands)
Balance, July 31, 2017	$	2,134		$	(4,477	)	$	(2,343	)
Other comprehensive loss attributable to IDT Corporation before reclassifications		(159	)		(38	)		(197	)
Less: reclassification for loss included in net loss		9			—			9		Other income (expense), net
Net other comprehensive loss attributable to IDT Corporation		(150	)		(38	)		(188	)
Balance, January 31, 2018	$	1,984		$	(4,515	)	$	(2,531	)

At both January 31, 2018 and July 31, 2017, unrealized gain on available-for-sale securities included unrealized gain of $2.1 million on the Rafael Pharma Series D Note.

XML

Business Segment Information

6 Months Ended

Jan. 31, 2018

Business Segment Information [Abstract]

Business Segment Information

Note 10—Business Segment Information

The Company has two reportable business segments, Telecom Platform Services and net2phone-Unified Communications as a Service (“net2phone-UCaaS”) (formerly known as UCaaS). The Company’s reportable segments are distinguished by types of service, customers and methods used to provide their services. The operating results of these business segments are regularly reviewed by the Company’s chief operating decision maker.

Telecom Platform Services and net2phone-UCaaS comprise the IDT Telecom division. The Telecom Platform Services segment provides retail telecommunications and payment offerings as well as wholesale international long distance traffic termination. The net2phone-UCaaS segment is comprised of (1) cable telephony, (2) cloud-based private branch exchange, or PBX, services offered to enterprise customers exclusively through value-added resellers, service providers, telecom agents and managed service providers, (3) Session Initiation Protocol, or SIP, trunking, which supports inbound and outbound domestic and international calling from an IP PBX, and (4) PicuP, a highly-automated business phone service that answers, routes and manages voice calls.

Beginning in the first quarter of fiscal 2018, the Telecom Platform Services segment includes Consumer Phone Services, which was previously reported as a separate segment. Consumer Phone Services provides consumer local and long distance services in certain U.S. states. Comparative results have been reclassified and restated as if Consumer Phone Services was included in Telecom Platform Services in all periods presented.

Operating segments not reportable individually are included in All Other. All Other includes the Company’s real estate holdings and other smaller businesses. Corporate costs include certain services, such as compensation, consulting fees, treasury and accounts payable, tax and accounting services, human resources and payroll, corporate purchasing, corporate governance including Board of Directors’ fees, internal and external audit, investor relations, corporate insurance, corporate legal, business development, and other corporate-related general and administrative expenses including, among others, facilities costs, charitable contributions and travel, as well as depreciation expense on corporate assets. Corporate does not generate any revenues, nor does it incur any direct cost of revenues.

The accounting policies of the segments are the same as the accounting policies of the Company as a whole. The Company evaluates the performance of its business segments based primarily on income (loss) from operations. IDT Telecom depreciation and amortization are allocated to Telecom Platform Services and net2phone-UCaaS because the related assets are not tracked separately by segment. There are no other significant asymmetrical allocations to segments.

Operating results for the business segments of the Company are as follows:

(in thousands)	Telecom Platform Services		net2phone-UCaaS			All Other			Corporate			Total
Three Months Ended January 31, 2018
Revenues	$	387,065	$	8,299		$	519		$	—		$	395,883
Income (loss) from operations		4,589		(790	)		(1,019	)		(3,260	)		(480	)
Severance		195		—			—			—			195
Other operating expense		—		—			—			(846	)		(846	)
Three Months Ended January 31, 2017
Revenues	$	359,924	$	7,142		$	490		$	—		$	367,556
Income (loss) from operations		7,187		(464	)		82			(3,677	)		3,128
Other operating expense		—		—			—			(889	)		(889	)
Six Months Ended January 31, 2018
Revenues	$	772,129	$	16,087		$	1,222		$	—		$	789,438
Income (loss) from operations		9,150		(1,464	)		(1,650	)		(6,433	)		(397	)
Severance		605		—			—			30			635
Other operating expense		—		—			—			(1,625	)		(1,625	)
Six Months Ended January 31, 2017
Revenues	$	721,435	$	14,278		$	994		$	—		$	736,707
Income (loss) from operations		13,732		(639	)		172			(4,951	)		8,314
Other operating expense		—		—			—			(1,088	)		(1,088	)

XML

Commitments and Contingencies

6 Months Ended

Jan. 31, 2018

Commitments and Contingencies [Abstract]

Commitments and Contingencies

Note 11—Commitments and Contingencies

Legal Proceedings

On July 31, 2013, the Company completed a pro rata distribution of the common stock of the Company’s subsidiary Straight Path Communications Inc. (“Straight Path”) to the Company’s stockholders of record as of the close of business on July 25, 2013 (the “Straight Path Spin-Off”). On July 5, 2017, plaintiff JDS1, LLC, on behalf of itself and all other similarly situated stockholders of Straight Path, and derivatively on behalf of Straight Path as nominal defendant, filed a putative class action and derivative complaint in the Court of Chancery of the State of Delaware against the Company, The Patrick Henry Trust (a trust formed by Howard S. Jonas that held record and beneficial ownership of certain shares of Straight Path he formerly held), Howard S. Jonas, and each of Straight Path’s directors. The complaint alleges that the Company aided and abetted Straight Path Chairman of the Board and Chief Executive Officer Davidi Jonas, and Howard S. Jonas in his capacity as controlling stockholder of Straight Path, in breaching their fiduciary duties to Straight Path in connection with the settlement of claims between Straight Path and the Company related to potential indemnification claims concerning Straight Path’s obligations under the Consent Decree it entered into with the Federal Communications Commission (“FCC”), as well as the proposed sale of Straight Path’s subsidiary Straight Path IP Group, Inc. (“SPIP”) to the Company in connection with that settlement. That action was consolidated with a similar action that was initiated by The Arbitrage Fund. The Plaintiffs are seeking, among other things, (i) a declaration that the action may be maintained as a class action or in the alternative, that demand on the Straight Path Board is excused; (ii) that the term sheet is invalid; (iii) awarding damages for the unfair price stockholders are receiving in the merger between Straight Path and Verizon Communications Inc. for their shares of Straight Path’s Class B common stock; and (iv) ordering Howard S. Jonas, Davidi Jonas, and the Company to disgorge any profits for the benefit of the class Plaintiffs. On August 28, 2017, the Plaintiffs filed an amended complaint. On September 24, 2017, the Company filed a motion to dismiss the amended complaint. The Company intends to vigorously defend the action. On November 20, 2017, the Delaware Chancery Court issued an order staying the case pending the closing of the transaction between Verizon and Straight Path on the grounds that the claims are not ripe. That transaction closed on February 28, 2018 and the Court was so notified. In the three and six months ended January 31, 2018, the Company incurred legal fees of $0.2 million and $1.0 million, respectively, related to this putative class action, which is included in “Other operating expense” in the accompanying consolidated statement of operations.

On May 5, 2004, the Company filed a complaint in the Supreme Court of the State of New York, County of New York, seeking injunctive relief and damages against Tyco Group, S.A.R.L., Tyco Telecommunications (US) Inc. (f/k/a TyCom (US) Inc.), Tyco International, Ltd., Tyco International (US) Inc., and TyCom Ltd. (collectively “Tyco”). The Company alleged that Tyco breached a settlement agreement that it had entered into with the Company to resolve certain disputes and civil actions among the parties. The Company alleged that Tyco did not provide the Company, as required under the settlement agreement, free of charge and for the Company’s exclusive use, a 15-year indefeasible right to use four Wavelengths in Ring Configuration (as defined in the settlement agreement) on a global undersea fiber optic network that Tyco was deploying at that time. After extensive proceedings, including several decisions and appeals, the New York Court of Appeals affirmed a lower court decision to dismiss the Company’s claim and denied the Company’s motion for re-argument of that decision. On June 23, 2015, the Company filed a new summons and complaint against Tyco in the Supreme Court of the State of New York, County of New York alleging that Tyco breached the settlement agreement. In September 2015, Tyco filed a motion to dismiss the complaint, which the Company opposed. Oral argument was held on March 9, 2016. On October 17, 2016, the judge granted Tyco’s motion and dismissed the complaint. In August 2017, the Company filed an appeal, which Tyco opposed. On November 22, 2017, oral argument was held on the appeal. On December 21, 2017, the Company’s appeal was denied. On January 22, 2018, the Company filed a motion for leave to appeal to the New York Court of Appeals. On February 6, 2018, Tyco opposed the Company’s motion. The Company awaits the court’s decision.

In addition to the foregoing, the Company is subject to other legal proceedings that have arisen in the ordinary course of business and have not been finally adjudicated. Although there can be no assurance in this regard, the Company believes that none of the other legal proceedings to which the Company is a party will have a material adverse effect on the Company’s results of operations, cash flows or financial condition.

Regulatory Fees Audit

The Company’s 2017 FCC Form 499-A, which reports its calendar year 2016 revenue, related to payments due to the FCC, is currently under audit by the Internal Audit Division of the Universal Service Administrative Company. At January 31, 2018 and July 31, 2017, the Company’s accrued expenses included $39.7 million and $43.5 million, respectively, for these regulatory fees for the years covered by the audit and subsequent years.

Purchase Commitments

The Company had purchase commitments of $18.7 million at January 31, 2018, including the aggregate commitment under the Reciprocal Services Agreement described below.

Reciprocal Services Agreement

In August 2017, the Company entered into a Reciprocal Services Agreement with a telecom operator in Central America for a full range of services, including, but not limited to, termination of inbound and outbound international long-distance voice calls. The Company has committed to pay such telecom operator monthly committed amounts during the term of the agreement. In addition, under certain limited circumstances, the parties may renegotiate the amount of the monthly payments. In the event the parties do not agree on re-pricing terms after good faith negotiations, then either party has the right to terminate the agreement. Pursuant to the agreement, in September 2017, the Company deposited $11.75 million into an escrow account as security for the benefit of the telecom operator, which is included in “Other current assets” in the accompanying consolidated balance sheet.

Performance Bonds

IDT Payment Services and IDT Telecom have performance bonds issued through third parties for the benefit of various states in order to comply with the states’ financial requirements for money remittance licenses and telecommunications resellers, respectively. At January 31, 2018, the Company had aggregate performance bonds of $15.1 million outstanding.

Substantially Restricted Cash and Cash Equivalents

The Company treats unrestricted cash and cash equivalents held by IDT Payment Services, which provides the Company’s international money transfer services in the United States, as substantially restricted and unavailable for other purposes. At January 31, 2018 and July 31, 2017, “Cash and cash equivalents” in the Company’s consolidated balance sheets included an aggregate of $10.0 million and $10.8 million, respectively, held by IDT Payment Services that was unavailable for other purposes.

Straight Path Communications Inc. Settlement Agreement and Mutual Release

The Company entered into various agreements with Straight Path prior to the Straight Path Spin-Off including a Separation and Distribution Agreement to effect the separation and provide a framework for the Company’s relationship with Straight Path after the spin-off. On September 20, 2016, the Company received a letter of inquiry from the Enforcement Bureau of the FCC requesting certain information and materials related to an investigation of potential violations by Straight Path Spectrum LLC (formerly a subsidiary of the Company and currently a subsidiary of Straight Path) in connection with licenses to operate on the 28 GHz and 39 GHz bands of the Fixed Microwave Services. The Company has cooperated with the FCC in this matter and has responded to the letter of inquiry. If the FCC were to pursue separate action against the Company, the FCC could seek to fine or impose regulatory penalties or civil liability on the Company related to activities during the period of ownership by the Company.

The Separation and Distribution Agreement provides for the Company and Straight Path to indemnify each other for certain liabilities. The Company and Straight Path each communicated that it was entitled to indemnification from the other in connection with the inquiry described above and related matters. On October 24, 2017, the Company, Straight Path, SPIP and PR-SP IP Holdings LLC (“PR-SP”), an entity owned by Howard Jonas, entered into a Settlement Agreement and Release that provides for, among other things, the settlement and mutual release of potential liabilities and claims that may exist or arise under the Separation and Distribution Agreement between the Company and Straight Path. In exchange for the mutual release, the Company paid Straight Path an aggregate of $16 million in cash, Straight Path transferred to the Company its majority ownership interest in Straight Path IP Group Holding, Inc. (“New SPIP”), which holds the equity of SPIP, the entity that holds intellectual property primarily related to communications over computer networks, subject to the right to receive 22% of the net proceeds, if any, received by SPIP from licenses, settlements, awards or judgments involving any of the patent rights and certain transfers of the patents or related rights, that will be retained by Straight Path’s stockholders (such equity interest, subject to the retained interest right, the “IP Interest”), and the Company undertook certain funding and other obligations related to SPIP. The Settlement Agreement and Release allocates (i) $10 million of the payment and the retained interest right to the settlement of claims and the mutual release and (ii) $6 million to the transfer of the IP Interest. 

Consistent with the contemplated arrangement that was previously disclosed, on October 24, 2017, the Company sold its entire majority interests in New SPIP to PR-SP in exchange for $6 million and the assumption by PR-SP of the funding and other obligations undertaken by the Company.

XML

Other Income (Expense), Net

6 Months Ended

Jan. 31, 2018

Other Income (Expense), Net [Abstract]

Other Income (Expense), Net

Note 12—Other Income (Expense), Net

Other income (expense), net consists of the following:

	Three Months Ended January 31,						Six Months Ended January 31,
	2018			2017			2018			2017
	(in thousands)
Foreign currency transaction gains (losses)	$	169		$	(729	)	$	(559	)	$	1,330
(Loss) gain on sale of marketable securities		(16	)		305			(9	)		305
Gain on investments		179			32			59			295
Other		38			(27	)		53			44
Total other income (expense), net	$	370		$	(419	)	$	(456	)	$	1,974

XML

Income Tax and New Jersey Corporation Business Tax

6 Months Ended

Jan. 31, 2018

Income Tax and New Jersey Corporation Business Tax [Abstract]

Income Tax and New Jersey Corporation Business Tax

Note 13—Income Tax and New Jersey Corporation Business Tax

Tax Cuts and Jobs Act

On December 22, 2017, the U.S. government enacted “An Act to Provide for Reconciliation Pursuant to Titles II and V of the Concurrent Resolution on the Budget for Fiscal Year 2018”, which is commonly referred to as “The Tax Cuts and Jobs Act” (the “Tax Act”). The Tax Act reduces the U.S. federal statutory corporate tax rate from 35.0% to 21.0% effective January 1, 2018, requires companies to pay a one-time repatriation tax on earnings of certain foreign subsidiaries that were previously tax deferred (“transition tax”), and makes other changes to the U.S. income tax code. Due to the Company’s July 31 fiscal year-end, the lower corporate income tax rate is phased in, resulting in a blended U.S. federal statutory tax rate of approximately 26.9% for the Company’s fiscal year ending July 31, 2018, and 21.0% for the Company’s fiscal years thereafter.

On December 22, 2017, the SEC issued Staff Accounting Bulletin No. 118 (“SAB 118”), expressing its views regarding the Financial Accounting Standards Board (“FASB”)’s Accounting Standards Codification 740, Income Taxes, in the reporting period that includes the enactment date of the Tax Act. SAB 118 recognizes that a registrant’s review of certain income tax effects of the Tax Act may be incomplete at the time financial statements are issued for the reporting period that includes the enactment date, including interim periods therein. Specifically, SAB 118 allows a company to report provisional estimates in the reporting period that includes the enactment date if the company does not have the necessary information available, prepared, or fully analyzed for certain income tax effects of the Tax Act. The provisional estimates would be adjusted during a measurement period not to exceed 12 months from the enactment date of the Tax Act, at which time the accounting for the income tax effects of the Tax Act is required to be completed.

As of January 31, 2018, the Company had not completed its accounting for the income tax effects of the Tax Act; however, the Company had made a reasonable estimate of the effect on its existing AMT credit carryover. Because the AMT credit will be refundable if not utilized in the next four years, the Company reversed the valuation allowance that offset the AMT credit. As a result, in the three months ended January 31, 2018, the Company recorded a noncurrent receivable and an income tax benefit of $3.3 million for the anticipated refund. The reduction in the corporate tax rate is not expected to impact the Company’s results of operations or financial position in the foreseeable future because the income tax benefit from the reduced tax rate will be offset by the valuation allowance.

The transition tax is based on total post-1986 earnings and profits which were previously deferred from U.S. income taxes. The Company expects to utilize net operating loss carryforwards to offset any transition tax that it may incur. Therefore the Company did not record any provisional income tax expense for the transition tax for its foreign subsidiaries. At January 31, 2018, the undistributed earnings of the Company’s foreign subsidiaries continued to be permanently reinvested and the Company does not intend to repatriate any of the amounts. As a result, the Company has not provided for additional income or withholding taxes for the undistributed earnings or for any additional outside basis differences with respect to the foreign entities. The Company continues to review the anticipated impacts of the global intangible low taxed income (“GILTI”) and base erosion anti-abuse tax (“BEAT”), which are not effective until August 1, 2018. The Company has not recorded any impact associated with either GILTI or BEAT in the three months ended January 31, 2018.

The Company anticipates that its assumptions and estimates may change as a result of future guidance and interpretation from the Internal Revenue Service, the SEC, the FASB, and various other taxing jurisdictions. In particular, the Company anticipates that the U.S. state jurisdictions will continue to determine and announce their conformity or decoupling from the Tax Act, either in its entirety or with respect to specific provisions. Legislative and interpretive actions could result in adjustments to the Company’s provisional estimates when the accounting for the income tax effects of the Tax Act is completed. The Company will continue to evaluate the impact of the Tax Act on its financial statements, and will record the effect of any reasonable changes in its estimates and adjustments.

Elmion Netherlands B.V. Deferred Tax Assets

In the six months ended January 31, 2017, the Company determined that its valuation allowance on the losses of Elmion Netherlands B.V., a Netherlands subsidiary, was no longer required due to an internal reorganization that generated income and a projection of income in future periods. The Company recorded a benefit from income taxes of $16.6 million in the six months ended January 31, 2017 from the full recognition of the Elmion Netherlands B.V. deferred tax assets.

New Jersey Corporation Business Tax

In September 2017, the Company, IDT Domestic Telecom, Inc. (a subsidiary of the Company) and certain other affiliates, were certified by the New Jersey Economic Development Authority as having met all of the requirements of the Grow New Jersey Assistance Act Tax Credit Program. The corporation business tax credits to be received are a maximum of $21.1 million. The Company may claim a tax credit each tax year for ten years beginning in 2017. The tax credit can be applied to 100% of the Company’s New Jersey tax liability each year, and the unused amount of the annual credit can be carried forward. In addition, the Company may apply for a tax credit transfer certificate to sell unused tax credits to another business. The tax credits must be sold for no less than 75% of the value of the tax credits. The tax credits are subject to reduction, forfeiture and recapture if, among other things, the number of full-time employees declines below the program or statewide minimum.

XML

Recently Issued Accounting Standard Not Yet Adopted

6 Months Ended

Jan. 31, 2018

Recently Issued Accounting Standard Not Yet Adopted [Abstract]

Recently Issued Accounting Standard Not Yet Adopted

Note 14—Recently Issued Accounting Standard Not Yet Adopted

In May 2014, the FASB and the International Accounting Standards Board jointly issued a comprehensive new revenue recognition standard that will supersede most of the current revenue recognition guidance under U.S. GAAP and International Financial Reporting Standards (“IFRS”). The goals of the revenue recognition project were to clarify and converge the revenue recognition principles under U.S. GAAP and IFRS and to develop guidance that would streamline and enhance revenue recognition requirements. Entities have the option of using either a full retrospective or modified retrospective approach for the adoption of the standard. The Company expects to adopt this standard on August 1, 2018 using the modified retrospective approach. The Company has identified its main revenue streams, which include Boss Revolution PIN-less international calling revenue, wholesale carrier services revenue, and domestic and international airtime top-up revenue. The Company is currently reviewing contracts and other relevant documents related to its wholesale carrier services revenue to determine how to apply the new standard to this revenue stream. The Company expects to continue its review and evaluation for its other revenue streams in fiscal 2018. Currently, the Company cannot reasonably estimate the impact that the adoption of the standard will have on its consolidated financial statements.

In January 2016, the FASB issued an ASU to provide more information about recognition, measurement, presentation and disclosure of financial instruments. The amendments in the ASU include, among other changes, the following: (1) equity investments (except those accounted for under the equity method or that result in consolidation) will be measured at fair value with changes in fair value recognized in net income, (2) a qualitative assessment each reporting period to identify impairment of equity investments without readily determinable fair values, (3) financial assets and financial liabilities will be presented separately by measurement category and form of financial asset on the balance sheet or the notes to the financial statements, and (4) an entity should evaluate the need for a valuation allowance on a deferred tax asset related to available-for-sale securities in combination with the entity’s other deferred tax assets. Entities will no longer be able to recognize unrealized holding gains and losses on equity securities classified as available-for-sale in other comprehensive income. In addition, a practicability exception will be available for equity investments that do not have readily determinable fair values and do not qualify for the net asset value practical expedient. These investments may be measured at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. Entities will have to reassess at each reporting period whether an investment qualifies for this practicability exception. The Company will adopt the amendments in this ASU on August 1, 2018. The Company is evaluating the impact that the ASU will have on its consolidated financial statements. 

In February 2016, the FASB issued an ASU related to the accounting for leases. The new standard establishes a right-of-use (“ROU”) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The Company will adopt the new standard on August 1, 2019. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is evaluating the impact that the new standard will have on its consolidated financial statements. 

In June 2016, the FASB issued an ASU that changes the impairment model for most financial assets and certain other instruments. For receivables, loans and other instruments, entities will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowance for losses. For available-for-sale debt securities with unrealized losses, entities will measure credit losses in a manner similar to current practice, except the losses will be recognized as allowances instead of reductions in the amortized cost of the securities. In addition, an entity will have to disclose significantly more information about allowances, credit quality indicators and past due securities. The new provisions will be applied as a cumulative-effect adjustment to retained earnings. The Company will adopt the new standard on August 1, 2020. The Company is evaluating the impact that the new standard will have on its consolidated financial statements.

In November 2016, the FASB issued an ASU that includes specific guidance on the classification and presentation of changes in restricted cash and cash equivalents in the statement of cash flows. The amendments in this ASU require that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Amounts generally described as restricted cash or restricted cash equivalents will be included with cash and cash equivalents when reconciling the beginning of the period and end of the period total amounts shown on the statement of cash flows. The ASU will be applied using a retrospective transition method to each period presented. The Company will adopt the amendments in this ASU on August 1, 2018. The adoption will impact the Company’s beginning of the period and end of the period cash and cash equivalents balance in its statement of cash flows, as well as its net cash provided by operating activities.

In January 2017, the FASB issued an ASU to clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. Under the current guidance, there are three elements of a business—inputs, processes, and outputs. While an integrated set of assets and activities (collectively referred to as a “set”) that is a business usually has outputs, outputs are not required to be present. In addition, all the inputs and processes that a seller uses in operating a set are not required if market participants can acquire the set and continue to produce outputs, for example, by integrating the acquired set with their own inputs and processes. The amendments in this ASU provide a screen to determine when a set is not a business. The screen requires that when substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single identifiable asset or a group of similar identifiable assets, the set is not a business. This screen reduces the number of transactions that need to be further evaluated. If the screen is not met, the amendments in this ASU (1) require that to be considered a business, a set must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create output and (2) remove the evaluation of whether a market participant could replace missing elements. The amendments provide a framework to assist entities in evaluating whether both an input and a substantive process are present. The framework includes two sets of criteria to consider that depend on whether a set has outputs. Although outputs are not required for a set to be a business, outputs generally are a key element of a business; therefore, the FASB has developed more stringent criteria for sets without outputs. Lastly, the ASU narrows the definition of the term output. The Company will adopt the amendments in this ASU on August 1, 2018. The Company is evaluating the impact that the new standard will have on its consolidated financial statements.

In May 2017, the FASB issued an ASU to provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. Pursuant to this ASU, an entity should account for the effects of a modification unless all the following are met: (1) the fair value (or calculated value or intrinsic value, if such an alternative measurement method is used) of the modified award is the same as the fair value (or calculated value or intrinsic value, if such an alternative measurement method is used) of the original award immediately before the original award is modified (if the modification does not affect any of the inputs to the valuation technique that the entity uses to value the award, the entity is not required to estimate the value immediately before and after the modification); (2) the vesting conditions of the modified award are the same as the vesting conditions of the original award immediately before the original award is modified; and (3) the classification of the modified award as an equity instrument or a liability instrument is the same as the classification of the original award immediately before the original award is modified. The Company will adopt the amendments in this ASU prospectively to an award modified on or after on August 1, 2018. The Company is evaluating the impact that the new standard will have on its consolidated financial statements.

In August 2017, the FASB issued an ASU intended to improve the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements. In addition, the ASU includes certain targeted improvements to simplify the application of hedge accounting guidance in U.S. GAAP. The amendments in this ASU are effective for the Company on August 1, 2019. Early application is permitted. Entities will apply the amendments to cash flow and net investment hedge relationships that exist on the date of adoption using a modified retrospective approach. The presentation and disclosure requirements will be applied prospectively. The Company is evaluating the impact that this ASU will have on its consolidated financial statements.

XML

IDT Financial Services Holding Limited Assets and Liabilities Held for Sale (Tables)

6 Months Ended

Jan. 31, 2018

IDT Financial Services Holding Limited Assets and Liabilities Held for Sale [Abstract]

Schedule of assets and liabilities held for sale

	January 31, 2018		July 31, 2017
	(in thousands)
Current assets held for sale:
Cash and cash equivalents	$	6,287	$	5,716
Restricted cash and cash equivalents		128,153		115,609
Trade accounts receivable, net of allowance for doubtful accounts of $3,239 and $2,550 at January 31, 2018 and July 31, 2017, respectively		2,919		1,844
Prepaid expenses		854		758
Other current assets		487		340
Total current assets held for sale	$	138,700	$	124,267
Noncurrent assets held for sale:
Property, plant and equipment, net	$	19	$	24
Other intangibles, net		164		165
Other assets		5,102		4,945
Total noncurrent assets held for sale	$	5,285	$	5,134
Current liabilities held for sale:
Trade accounts payable	$	2,007	$	372
Accrued expenses		252		226
Customer deposits		127,107		114,689
Other current liabilities		57		31
Total current liabilities held for sale	$	129,423	$	115,318
Noncurrent liabilities held for sale:
Other liabilities	$	642	$	550
Total noncurrent liabilities held for sale	$	642	$	550

Schedule of consolidated statements of operations

	Three Months Ended January 31,						Six Months Ended January 31,
	2018			2017			2018			2017
	(in thousands)
(Loss) income before income taxes	$	(559	)	$	(421	)	$	(1,009	)	$	174
(Loss) income before income taxes attributable to IDT Corporation	$	(559	)	$	(421	)	$	(1,009	)	$	174

XML

Proposed Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc. (Tables)

6 Months Ended

Jan. 31, 2018

Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc. [Abstract]

Schedule of consolidated balance sheets

	January 31, 2018		July 31, 2017
	(in thousands)
Series D Note (at fair value)	$	6,300	$	6,300
Warrants (at cost)		5,400		5,400
Right to receive additional shares (at cost)		—		400
Total investment in Rafael Pharma	$	11,700	$	12,100

XML

Marketable Securities (Tables)

6 Months Ended

Jan. 31, 2018

Marketable Securities [Abstract]

Summary of marketable securities

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
	(in thousands)
Available-for-sale securities:
January 31, 2018:
Certificates of deposit*	$	24,441	$	2	$	(1	)	$	24,442
Federal Government Sponsored Enterprise notes		3,216		—		(26	)		3,190
International agency notes		399		—		(9	)		390
Mutual funds		5,425		40		—			5,465
Corporate bonds		3,332		—		(39	)		3,293
Equity		79		—		(3	)		76
U.S. Treasury notes		5,397		—		(76	)		5,321
Municipal bonds		4,029		—		(4	)		4,025
Total	$	46,318	$	42	$	(158	)	$	46,202
July 31, 2017:
Certificates of deposit*	$	29,011	$	1	$	(7	)	$	29,005
Federal Government Sponsored Enterprise notes		3,992		—		(14	)		3,978
International agency notes		291		—		—			291
Mutual funds		5,353		77		—			5,430
Corporate bonds		4,643		—		—			4,643
Equity		74		—		(26	)		48
U.S. Treasury notes		6,673		—		—			6,673
Municipal bonds		8,201		4		(1	)		8,204
Total	$	58,238	$	82	$	(48	)	$	58,272

* Each of the Company’s certificates of deposit has a CUSIP, was purchased in the secondary market through a broker, and may be sold in the secondary market.

Summary of available-for-sale debt securities

	Fair Value
	(in thousands)
Within one year	$	25,771
After one year through five years		14,890
After five years through ten years		—
After ten years		—
Total	$	40,661

Summary of available-for-sale securities, unrealized loss position

	Unrealized Losses		Fair Value
	(in thousands)
January 31, 2018:
Certificates of deposit	$	1	$	5,340
Federal Government Sponsored Enterprise notes		26		3,190
International agency notes		9		390
Corporate bonds		39		3,293
Equity		3		76
U.S. Treasury notes		76		5,321
Municipal bonds		4		3,067
Total	$	158	$	20,677
July 31, 2017:
Certificates of deposit	$	7	$	12,155
Federal Government Sponsored Enterprise notes		14		3,529
Equity		26		48
Municipal bonds		1		3,349
Total	$	48	$	19,081

Summary of available-for-sale securities, continuous unrealized loss position

	Unrealized Losses		Fair Value
	(in thousands)
Federal Government Sponsored Enterprise notes	$	13	$	1,810
Municipal bonds		1		348
Total	$	14	$	2,158

XML

Fair Value Measurements (Tables)

6 Months Ended

Jan. 31, 2018

Fair Value Measurements [Abstract]

Summary of balance of assets measured at fair value on a recurring basis

	Level 1 (1)		Level 2 (2)		Level 3 (3)		Total
	(in thousands)
January 31, 2018
Available-for-sale securities:
Marketable securities	$	10,862	$	35,340	$	—	$	46,202
Rafael Pharma Series D Note		—		—		6,300		6,300
Total	$	10,862	$	35,340	$	6,300	$	52,502
July 31, 2017
Available-for-sale securities:
Marketable securities	$	12,151	$	46,121	$	—	$	58,272
Rafael Pharma Series D Note		—		—		6,300		6,300
Total	$	12,151	$	46,121	$	6,300	$	64,572

(1) – quoted prices in active markets for identical assets or liabilities

(2) – observable inputs other than quoted prices in active markets for identical assets and liabilities

(3) – no observable pricing inputs in the market

Summary of assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3)

	Three Months Ended January 31,				Six Months Ended January 31,
	2018		2017		2018		2017
	(in thousands)
Balance, beginning of period	$	6,300	$	4,200	$	6,300	$	2,000
Purchases		—		—		—		2,200
Balance, end of period	$	6,300	$	4,200	$	6,300	$	4,200
Change in unrealized gains or losses for the period included in earnings for assets held at the end of the period	$	—	$	—	$	—	$	—

XML

Equity (Tables)

6 Months Ended

Jan. 31, 2018

Equity [Abstract]

Summary of changes in the components of equity

	Six Months Ended  January 31, 2018
	Attributable to IDT Corporation			Noncontrolling Interests			Total
	(in thousands)
Balance, July 31, 2017	$	145,734		$	8,823		$	154,557
Dividends declared ($0.38 per share)		(9,440	)		—			(9,440	)
Restricted Class B common stock purchased from employees		(61	)		—			(61	)
Transfer of right to receive equity to Howard S. Jonas		—			(40	)		(40	)
Consolidation of Lipomedix Pharmaceuticals Ltd.		—			558			558
Distributions to noncontrolling interests		—			(717	)		(717	)
Stock-based compensation		1,797			—			1,797
Comprehensive income:
Net loss		(576	)		470			(106	)
Other comprehensive loss		(188	)		—			(188	)
Comprehensive income		(764	)		470			(294	)
Balance, January 31, 2018	$	137,266		$	9,094		$	146,360

XML

Earnings (Loss) Per Share (Tables)

6 Months Ended

Jan. 31, 2018

(Loss) Earnings Per Share [Abstract]

Summary of weighted-average number of shares used in the calculation of basic and diluted (loss) earnings per share

	Three Months Ended January 31,				Six Months Ended January 31,
	2018		2017		2018		2017
	(in thousands)
Basic weighted-average number of shares		24,643		22,768		24,635		22,740
Effect of dilutive securities:
Stock options		10		77		—		58
Non-vested restricted Class B common stock		71		118		—		133
Diluted weighted-average number of shares		24,724		22,963		24,635		22,931

Summary of shares excluded from the diluted earnings per share

	Three Months Ended January 31,				Six Months Ended January 31,
	2018		2017		2018		2017
	(in thousands)
Stock options		1,160		3		1,273		18
Non-vested restricted Class B common stock		—		—		191		—
Shares excluded from the calculation of diluted earnings per share		1,160		3		1,464		18

XML

Accumulated Other Comprehensive Loss (Tables)

6 Months Ended

Jan. 31, 2018

Accumulated Other Comprehensive Loss [Abstract]

Schedule of accumulated balances for each classification of other comprehensive loss

	Unrealized Gain (Loss) on Available-for-Sale Securities			Foreign Currency Translation			Accumulated Other Comprehensive Loss			Location of (Gain) Loss Recognized
	(in thousands)
Balance, July 31, 2017	$	2,134		$	(4,477	)	$	(2,343	)
Other comprehensive loss attributable to IDT Corporation before reclassifications		(159	)		(38	)		(197	)
Less: reclassification for loss included in net loss		9			—			9		Other income (expense), net
Net other comprehensive loss attributable to IDT Corporation		(150	)		(38	)		(188	)
Balance, January 31, 2018	$	1,984		$	(4,515	)	$	(2,531	)

XML

Business Segment Information (Tables)

6 Months Ended

Jan. 31, 2018

Business Segment Information [Abstract]

Summary of operating results of business segments

(in thousands)	Telecom Platform Services		net2phone-UCaaS			All Other			Corporate			Total
Three Months Ended January 31, 2018
Revenues	$	387,065	$	8,299		$	519		$	—		$	395,883
Income (loss) from operations		4,589		(790	)		(1,019	)		(3,260	)		(480	)
Severance		195		—			—			—			195
Other operating expense		—		—			—			(846	)		(846	)
Three Months Ended January 31, 2017
Revenues	$	359,924	$	7,142		$	490		$	—		$	367,556
Income (loss) from operations		7,187		(464	)		82			(3,677	)		3,128
Other operating expense		—		—			—			(889	)		(889	)
Six Months Ended January 31, 2018
Revenues	$	772,129	$	16,087		$	1,222		$	—		$	789,438
Income (loss) from operations		9,150		(1,464	)		(1,650	)		(6,433	)		(397	)
Severance		605		—			—			30			635
Other operating expense		—		—			—			(1,625	)		(1,625	)
Six Months Ended January 31, 2017
Revenues	$	721,435	$	14,278		$	994		$	—		$	736,707
Income (loss) from operations		13,732		(639	)		172			(4,951	)		8,314
Other operating expense		—		—			—			(1,088	)		(1,088	)

XML

Other Income (Expense), Net (Tables)

6 Months Ended

Jan. 31, 2018

Other Income (Expense), Net [Abstract]

Schedule of other (expense) income, net

	Three Months Ended January 31,						Six Months Ended January 31,
	2018			2017			2018			2017
	(in thousands)
Foreign currency transaction gains (losses)	$	169		$	(729	)	$	(559	)	$	1,330
(Loss) gain on sale of marketable securities		(16	)		305			(9	)		305
Gain on investments		179			32			59			295
Other		38			(27	)		53			44
Total other income (expense), net	$	370		$	(419	)	$	(456	)	$	1,974

XML

IDT Financial Services Holding Limited Assets and Liabilities Held for Sale (Details) - USD ($) $ in Thousands	Jan. 31, 2018	Jul. 31, 2017
Current assets held for sale:
Cash and cash equivalents	$ 6,287	$ 5,716
Total current assets held for sale	138,700	124,267
Noncurrent assets held for sale:
Other assets	5,285	5,134
Current liabilities held for sale:
Total current liabilities held for sale	129,423	115,318
Noncurrent liabilities held for sale:
Total noncurrent liabilities held for sale	642	550
IDT Financial Services Holding Limited [Member]
Current assets held for sale:
Cash and cash equivalents	6,287	5,716
Restricted cash and cash equivalents	128,153	115,609
Trade accounts receivable, net of allowance for doubtful accounts of $3,239 and $2,550 at January 31, 2018 and July 31, 2017, respectively	2,919	1,844
Prepaid expenses	854	758
Other current assets	487	340
Total current assets held for sale	138,700	124,267
Noncurrent assets held for sale:
Property, plant and equipment, net	19	24
Other intangibles, net	164	165
Other assets	5,102	4,945
Total noncurrent assets held for sale	5,285	5,134
Current liabilities held for sale:
Trade accounts payable	2,007	372
Accrued expenses	252	226
Customer deposits	127,107	114,689
Other current liabilities	57	31
Total current liabilities held for sale	129,423	115,318
Noncurrent liabilities held for sale:
Other liabilities	642	550
Total noncurrent liabilities held for sale	$ 642	$ 550

XML

IDT Financial Services Holding Limited Assets and Liabilities Held for Sale (Details 1) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2018	Jan. 31, 2017	Jan. 31, 2018	Jan. 31, 2017
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
(Loss) income before income taxes	$ 176	$ 3,018	$ (205)	$ 10,897
IDT Financial Services Holding Limited [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
(Loss) income before income taxes	(559)	(421)	1,009	174
(Loss) income before income taxes attributable to IDT Corporation	$ (559)	$ (421)	$ 1,009	$ 174

XML

IDT Financial Services Holding Limited Assets and Liabilities Held for Sale (Details Textual) - USD ($) $ in Thousands	6 Months Ended
	Jan. 31, 2018	Jul. 31, 2017
IDT Financial Services Holding Limited Assets and Liabilities Held for Sale (Textual)
Allowance for doubtful accounts	$ 3,239	$ 2,550
Net asset value	14,500
IDT Financial Services Holding Limited [Member]
IDT Financial Services Holding Limited Assets and Liabilities Held for Sale (Textual)
Outstanding equity interests	$ 4,100

XML

Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc. (Details) - Rafael Pharma [Member] - USD ($) $ in Thousands	Jan. 31, 2018	Jul. 31, 2017
Schedule of consolidated balance sheets
Series D Note (at fair value)	$ 6,300	$ 6,300
Warrants (at cost)	5,400	5,400
Right to receive additional shares (at cost)		400
Total investment in Rafael Pharma	$ 11,700	$ 12,100

XML

Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc. (Details Textual) - USD ($) $ in Thousands	6 Months Ended
	Jan. 31, 2018	Sep. 19, 2017	Sep. 14, 2017	Jul. 31, 2017
Proposed Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc. (Textual)
Marketable securities	$ 46,202			$ 58,272
Series C convertible notes	24,350			$ 26,894
Howard S. Jonas [Member] | IDT Corporation [Member]
Proposed Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc. (Textual)
Percentage of contractual right to receive additional shares		9.00%
Rafael Holdings, Inc. [Member]
Proposed Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc. (Textual)
Spin off cash and marketable securities to be distributed	44,000
Investments	6,000
Rafael Pharmaceuticals, Inc. [Member]
Proposed Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc. (Textual)
Maximum exposure to loss	11,700
Rafael Pharmaceuticals, Inc. [Member] | Convertible promissory note [Member] | Howard and Deborah Jonas [Member]
Proposed Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc. (Textual)
Series C convertible notes	525
Rafael Pharmaceuticals, Inc. [Member] | Convertible promissory note [Member] | The Howard S. and Deborah Jonas Foundation [Member]
Proposed Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc. (Textual)
Series C convertible notes	$ 525
CS Pharma Holdings, LLC [Member]
Proposed Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc. (Textual)
Holds percentages of interest	50.00%
CS Pharma Holdings, LLC [Member] | Convertible promissory note ("Series D Note") [Member]
Proposed Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc. (Textual)
Purchase shares of capital stock percentage	56.00%
Exercise warrants value	$ 10,000
Warrant, description	The exercise price of the warrant is the lower of 70% of the price sold in an equity financing, or $1.25 per share, subject to certain adjustments. The minimum initial and subsequent exercises of the warrant shall be for such number of shares that will result in at least $5 million of gross proceeds to Rafael Pharma, or such lesser amount as represents 5% of the outstanding capital stock of Rafael Pharma, or such lesser amount as may then remain unexercised. The warrant will expire upon the earlier of December 31, 2020 or a qualified initial public offering or liquidation event.
Warrants expiry date	Dec. 31, 2020
Convertible promissory note, principal amount	$ 10,000
Convertible promissory note, rate of interest	3.50%
Convertible promissory note, maturity date	Sep. 16, 2018
Initial amount of investment amounts paid	$ 5,000
Convertible notes conversion features, description	The Series D Note also includes a mandatory conversion into Rafael Pharma common stock upon a qualified initial public offering, and conversion at the holder's option upon an unqualified financing event. In all cases, the Series D Note conversion price is based on the applicable financing purchase price.
IDT-Rafael Holdings, LLC [Member]
Proposed Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc. (Textual)
Contractual right to receive additional shares, description	(i) Food and Drug Administration approval of a Rafael Pharma drug application, (ii) an initial public offering of Rafael Pharma at a valuation of over $500 million, or (iii) a sale of Rafael Pharma above certain valuations. Currently, none of the conditions have been satisfied and the right remains contingent. On September 14, 2017, IDT-Rafael Holdings distributed this right to its members on a pro rata basis such that the Company received the right to 9% of the outstanding capital stock of Rafael Pharma and Howard S. Jonas, the Company's Chairman of the Board, and Chairman of the Board of Rafael Pharma, received the right to 1% of the outstanding capital stock of Rafael Pharma. In addition, as compensation for assuming the role of Chairman of the Board of Rafael Pharma, and to create additional incentive to contribute to the success of Rafael Pharma, on September 19, 2017, the Company transferred its right to receive 9% of the outstanding capital stock of Rafael Pharma to Mr. Jonas. The right is further transferable at the discretion of Mr. Jonas.
Percentage of contractual right to receive additional shares	10.00%
IDT-Rafael Holdings, LLC [Member] | IDT Corporation [Member]
Proposed Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc. (Textual)
Percentage of contractual right to receive additional shares			9.00%
IDT-Rafael Holdings, LLC [Member] | Howard S. Jonas [Member]
Proposed Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc. (Textual)
Percentage of contractual right to receive additional shares			1.00%
Holds percentages of interest	10.00%
IDT-Rafael Holdings, LLC [Member] | Rafael Holdings, Inc. [Member]
Proposed Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc. (Textual)
Holds percentages of interest	90.00%

XML

Marketable Securities (Details) - USD ($) $ in Thousands		Jan. 31, 2018		Jul. 31, 2017
Available-for-sale securities:
Amortized Cost		$ 46,318		$ 58,238
Gross Unrealized Gains, Total		42		82
Gross Unrealized Losses, Total		(158)		(48)
Fair Value		46,202		58,272
Certificates of deposit [Member]
Available-for-sale securities:
Amortized Cost	[1]	24,441		29,011
Gross Unrealized Gains	[1]	2		1
Unrealized Losses		(1)	[2]	(7)	[1]
Fair Value	[1]	24,442		29,005
Federal Government Sponsored Enterprise notes [Member]
Available-for-sale securities:
Amortized Cost		3,216		3,992
Gross Unrealized Gains
Unrealized Losses		(26)		(14)
Fair Value		3,190		3,978
International agency notes [Member]
Available-for-sale securities:
Amortized Cost		399		291
Gross Unrealized Gains
Unrealized Losses		(9)
Fair Value		390		291
Mutual funds [Member]
Available-for-sale securities:
Amortized Cost		5,425		5,353
Gross Unrealized Gains		40		77
Gross Unrealized Losses
Fair Value		5,465		5,430
Corporate bonds [Member]
Available-for-sale securities:
Amortized Cost		3,332		4,643
Gross Unrealized Gains
Unrealized Losses		(39)
Fair Value		3,293		4,643
Equity [Member]
Available-for-sale securities:
Amortized Cost		79		74
Gross Unrealized Gains
Gross Unrealized Losses		(3)		(26)
Fair Value		76		48
U.S. Treasury notes [Member]
Available-for-sale securities:
Amortized Cost		5,397		6,673
Gross Unrealized Gains
Unrealized Losses		(76)
Fair Value		5,321		6,673
Municipal bonds [Member]
Available-for-sale securities:
Amortized Cost		4,029		8,201
Gross Unrealized Gains				4
Unrealized Losses		(4)		(1)
Fair Value		$ 4,025		$ 8,204

[1] Each of the Company's certificates of deposit has a CUSIP, was purchased in the secondary market through a broker, and may be sold in the secondary market.

[2] Stock-based compensation included in selling, general and administrative expenses

XML

Marketable Securities (Details 1) $ in Thousands	Jan. 31, 2018 USD ($)
Marketable Securities [Abstract]
Within one year	$ 25,771
After one year through five years	14,890
After five years through ten years
After ten years
Total	$ 40,661

XML

Marketable Securities (Details 2) - USD ($) $ in Thousands	Jan. 31, 2018	Jul. 31, 2017
Schedule of Available-for-sale Securities [Line Items]
Unrealized Losses	$ 158	$ 48
Fair Value	20,677	19,081
Certificates of deposit [Member]
Schedule of Available-for-sale Securities [Line Items]
Unrealized Losses	1	7
Fair Value	5,340	12,155
Federal Government Sponsored Enterprise notes [Member]
Schedule of Available-for-sale Securities [Line Items]
Unrealized Losses	26	14
Fair Value	3,190	3,529
International agency notes [Member]
Schedule of Available-for-sale Securities [Line Items]
Unrealized Losses	9
Fair Value	390
Corporate bonds [Member]
Schedule of Available-for-sale Securities [Line Items]
Unrealized Losses	39
Fair Value	3,293
Equity [Member]
Schedule of Available-for-sale Securities [Line Items]
Unrealized Losses	3	26
Fair Value	76	48
U.S. Treasury notes [Member]
Schedule of Available-for-sale Securities [Line Items]
Unrealized Losses	76
Fair Value	5,321
Municipal bonds [Member]
Schedule of Available-for-sale Securities [Line Items]
Unrealized Losses	4	1
Fair Value	$ 3,067	$ 3,349

XML

Marketable Securities (Details 3) $ in Thousands	Jan. 31, 2018 USD ($)
Available-for-sale securities:
Unrealized Losses	$ 14
Fair Value	2,158
Federal Government Sponsored Enterprise notes [Member]
Available-for-sale securities:
Unrealized Losses	13
Fair Value	1,810
Municipal Bonds [Member]
Available-for-sale securities:
Unrealized Losses	1
Fair Value	$ 348

XML

Marketable Securities (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Jan. 31, 2018	Jan. 31, 2017	Jan. 31, 2018	Jan. 31, 2017	Jul. 31, 2017
Marketable Securities (Textual)
Proceeds from maturities and sales of available-for-sale securities	$ 12,100,000	$ 10,800,000	$ 31,600,000	$ 16,800,000
Unrealized losses, less than twelve months or longer	14,000		14,000
Gross realized gains		$ 300,000		$ 300,000
Gross realized losses	$ (16,000)		$ (9,000)
Zedge [Member]
Marketable Securities (Textual)
Shares	24,923		24,923		23,227
Shares owned fair value	$ 76,000		$ 76,000		$ 48,000

XML

Fair Value Measurements (Details) - USD ($) $ in Thousands		Jan. 31, 2018	Jul. 31, 2017
Available-for-sale securities:
Marketable securities		$ 46,202	$ 58,272
Rafael Pharma Series D Note		6,300	6,300
Total		52,502	64,572
Fair Value Measurements, Recurring basis [Member] | Level 1 [Member]
Available-for-sale securities:
Marketable securities	[1]	10,862	12,151
Rafael Pharma Series D Note	[1]
Total	[1]	10,862	12,151
Fair Value Measurements, Recurring basis [Member] | Level 2 [Member]
Available-for-sale securities:
Marketable securities	[2]	35,340	46,121
Rafael Pharma Series D Note	[2]
Total	[2]	35,340	46,121
Fair Value Measurements, Recurring basis [Member] | Level 3 [Member]
Available-for-sale securities:
Marketable securities	[3]
Rafael Pharma Series D Note	[3]	6,300	6,300
Total	[3]	$ 6,300	$ 6,300

[1] quoted prices in active markets for identical assets or liabilities

[2] observable inputs other than quoted prices in active markets for identical assets and liabilities

[3] no observable pricing inputs in the market

XML

Fair Value Measurements (Details 1) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2018	Jan. 31, 2017	Jan. 31, 2018	Jan. 31, 2017
Fair Value Measurements [Abstract]
Balance, beginning of period	$ 6,300	$ 4,200	$ 6,300	$ 2,000
Purchases				2,200
Balance, end of period	6,300	4,200	6,300	4,200
Change in unrealized gains or losses for the period included in earnings for assets held at the end of the period

XML

Fair Value Measurements (Details Textual) - USD ($) $ in Millions	Jan. 31, 2018	Jul. 31, 2017
Fair Value Measurements (Textual)
Fair value of investments in hedge funds	$ 8.8	$ 8.6
Carrying value of investments	$ 10.4	$ 10.8

XML

Equity (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2018	Jan. 31, 2017	Jan. 31, 2018	Jan. 31, 2017
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance			$ 154,557
Dividends declared ($0.38 per share)			(9,440)
Restricted Class B common stock purchased from employees			(61)
Transfer of right to receive equity to Howard S. Jonas			(40)
Consolidation of Lipomedix Pharmaceuticals Ltd.			558
Distributions to noncontrolling interests			(717)
Stock-based compensation			1,797
Comprehensive income:
Net loss	$ 1,690	$ 1,257	(106)	$ 23,552
Other comprehensive loss	210	419	(188)	(2,466)
Comprehensive income	1,900	$ 1,676	(294)	$ 21,086
Ending Balance	146,360		146,360
Attributable to IDT Corporation [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance			145,734
Dividends declared ($0.38 per share)			(9,440)
Restricted Class B common stock purchased from employees			(61)
Transfer of right to receive equity to Howard S. Jonas
Consolidation of Lipomedix Pharmaceuticals Ltd.
Distributions to noncontrolling interests
Stock-based compensation			1,797
Comprehensive income:
Net loss			(576)
Other comprehensive loss			(188)
Comprehensive income			(764)
Ending Balance	137,266		137,266
Noncontrolling Interests [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance			8,823
Dividends declared ($0.38 per share)
Restricted Class B common stock purchased from employees
Transfer of right to receive equity to Howard S. Jonas			(40)
Consolidation of Lipomedix Pharmaceuticals Ltd.			558
Distributions to noncontrolling interests			(717)
Stock-based compensation
Comprehensive income:
Net loss			470
Other comprehensive loss
Comprehensive income			470
Ending Balance	$ 9,094		$ 9,094

XML

Equity (Details Textual) - USD ($) $ / shares in Units, $ in Thousands			6 Months Ended
	Mar. 05, 2018	Dec. 14, 2017	Jan. 31, 2018	Jan. 31, 2017	Oct. 31, 2016
Equity (Textual)
Dividends paid per share in cash			$ 0.38
Proceeds from exercise of stock options				$ 835
Common Stock [Member]
Equity (Textual)
Aggregate dividends paid on common stock including Class A and Class B.			$ 9,400		$ 8,800
Common Class A [Member]
Equity (Textual)
Dividends paid per share in cash			$ 0.38		$ 0.38
Common Class A [Member] | Subsequent Event [Member]
Equity (Textual)
Dividends paid per share in cash	$ 0.09
Paid date of declared dividend	Mar. 23, 2018
Record date of declared dividend	Mar. 19, 2018
Common Class B [Member]
Equity (Textual)
Dividends paid per share in cash			$ 0.38	$ 0.38
Class B common stock shares purchased options			8,000,000
Stock repurchase program, remaining number of shares authorized to be repurchased			8,000,000
Common Class B [Member] | Subsequent Event [Member]
Equity (Textual)
Dividends paid per share in cash	$ 0.09
Paid date of declared dividend	Mar. 23, 2018
Record date of declared dividend	Mar. 19, 2018
Common Class B [Member] | Employee [Member]
Equity (Textual)
Aggregate purchase price of shares repurchased			$ 100	$ 1,800
Class B common stock shares repurchased			5,170	94,338
Common Class B [Member] | 2015 Stock Option and Incentive Plan [Member]
Equity (Textual)
Additional shares available stock option incentive plan for grants		300,000
Proceeds from exercise of stock options				$ 800,000
Stock issued for stock option exercises				73,471

XML

Earnings (Loss) Per Share (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2018	Jan. 31, 2017	Jan. 31, 2018	Jan. 31, 2017
Weighted-average number of shares used in the calculation of basic and diluted earnings per share
Basic weighted-average number of shares	24,643	22,768	24,635	22,740
Effect of dilutive securities:
Stock options	10	77		58
Non-vested restricted Class B common stock	71	118		133
Diluted weighted-average number of shares	24,724	22,963	24,635	22,931

XML

Earnings (Loss) Per Share (Details 1) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2018	Jan. 31, 2017	Jan. 31, 2018	Jan. 31, 2017
Stock options excluded from the diluted earnings per share computations
Shares excluded from the calculation of diluted earnings per share	1,160	3	1,464	18
Non-vested restricted Class B common stock [Member]
Stock options excluded from the diluted earnings per share computations
Shares excluded from the calculation of diluted earnings per share			191
Stock options [Member]
Stock options excluded from the diluted earnings per share computations
Shares excluded from the calculation of diluted earnings per share	1,160	3	1,273	18

XML

Revolving Credit Facility (Details) $ in Millions		6 Months Ended
	Jul. 12, 2012 USD ($) BasisPoint	Jan. 31, 2018 USD ($)	Jul. 31, 2017 USD ($)
Revolving Credit Facility (Textual)
Maximum principal amount of credit agreement	$ 25.0
Unused outstanding amount	$ 25.0
Line of credit maturity date		Jan. 31, 2020
Average percentage of commitment fee per annum	0.325%
Line of credit [Member]
Revolving Credit Facility (Textual)
Line of credit facility, outstanding
July 12, 2012 [Member]
Revolving Credit Facility (Textual)
Interest rate description		The principal outstanding bears interest per annum, at the option of IDT Telecom, at either (a) the U.S. Prime Rate less 125 basis points, or (b) the LIBOR rate adjusted by the Regulation D maximum reserve requirement plus 125 basis points.
Prime Rate [Member]
Revolving Credit Facility (Textual)
U.S. Prime rate basis points | BasisPoint	125

XML

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2018	Jan. 31, 2017	Jan. 31, 2018	Jan. 31, 2017
Schedule of accumulated balances for each classification of other comprehensive income (loss)
Beginning balance			$ (2,343)
Net other comprehensive loss attributable to IDT Corporation	$ 210	$ 419	(188)	$ (2,466)
Ending balance	(2,531)		(2,531)
Unrealized Gain (Loss) on Available-for-Sale Securities [Member]
Schedule of accumulated balances for each classification of other comprehensive income (loss)
Beginning balance			2,134
Other comprehensive loss attributable to IDT Corporation before reclassifications			(159)
Net other comprehensive loss attributable to IDT Corporation			(150)
Ending balance	1,984		1,984
Unrealized Gain (Loss) on Available-for-Sale Securities [Member] | Other income (expense), net [Member]
Schedule of accumulated balances for each classification of other comprehensive income (loss)
Less: reclassification for loss included in net loss			9
Foreign Currency Translation [Member]
Schedule of accumulated balances for each classification of other comprehensive income (loss)
Beginning balance			(4,477)
Other comprehensive loss attributable to IDT Corporation before reclassifications			(38)
Net other comprehensive loss attributable to IDT Corporation			(38)
Ending balance	(4,515)		(4,515)
Foreign Currency Translation [Member] | Other income (expense), net [Member]
Schedule of accumulated balances for each classification of other comprehensive income (loss)
Less: reclassification for loss included in net loss
Accumulated Other Comprehensive Loss [Member]
Schedule of accumulated balances for each classification of other comprehensive income (loss)
Beginning balance			(2,343)
Other comprehensive loss attributable to IDT Corporation before reclassifications			(197)
Net other comprehensive loss attributable to IDT Corporation			(188)
Ending balance	$ (2,531)		(2,531)
Accumulated Other Comprehensive Loss [Member] | Other income (expense), net [Member]
Schedule of accumulated balances for each classification of other comprehensive income (loss)
Less: reclassification for loss included in net loss			$ 9

XML

Accumulated Other Comprehensive Loss (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jan. 31, 2018	Jan. 31, 2017	Jan. 31, 2018	Jan. 31, 2017	Jul. 31, 2017
Accumulated Other Comprehensive Loss (Textual)
Net other comprehensive income (loss) attributable to IDT Corporation	$ 210	$ 419	$ (188)	$ (2,466)
Unrealized gain (loss) on available-for-sale securities [Member]
Accumulated Other Comprehensive Loss (Textual)
Net other comprehensive income (loss) attributable to IDT Corporation			(150)
Unrealized gain (loss) on available-for-sale securities [Member] | Rafael Pharmaceuticals, Inc. Series D Note [Member]
Accumulated Other Comprehensive Loss (Textual)
Net other comprehensive income (loss) attributable to IDT Corporation			$ 2,100		$ 2,100

XML

Business Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2018	Jan. 31, 2017	Jan. 31, 2018	Jan. 31, 2017
Segment Reporting Information [Line Items]
Revenues	$ 395,883	$ 367,556	$ 789,438	$ 736,707
Income (loss) from operations	(480)	3,128	(397)	8,314
Severance	195		635
Other operating expense	(846)	(889)	(1,625)	(1,088)
Operating Segments [Member] | Telecom Platform Services [Member]
Segment Reporting Information [Line Items]
Revenues	387,065	359,924	772,129	721,435
Income (loss) from operations	4,589	7,187	9,150	13,732
Severance	195		605
Other operating expense
Operating Segments [Member] | net2phone-UCaaS [Member]
Segment Reporting Information [Line Items]
Revenues	8,299	7,142	16,087	14,278
Income (loss) from operations	(790)	(464)	(1,464)	(639)
Severance
Other operating expense
Operating Segments [Member] | All Other [Member]
Segment Reporting Information [Line Items]
Revenues	519	490	1,222	994
Income (loss) from operations	(1,019)	82	(1,650)	172
Severance
Other operating expense
Operating Segments [Member] | Corporate [Member]
Segment Reporting Information [Line Items]
Revenues
Income (loss) from operations	(3,260)	(3,677)	(6,433)	(4,951)
Severance			30
Other operating expense	$ (846)	$ (889)	$ (1,625)	$ (1,088)

XML

Business Segment Information (Details Textual)	6 Months Ended
	Jan. 31, 2018 Segment
Business Segment Information (Textual)
Number of reportable segments	2

XML

Commitments and Contingencies (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
	Oct. 24, 2017	Jan. 31, 2018	Jan. 31, 2017	Jan. 31, 2018	Jan. 31, 2017	Sep. 30, 2017	Jul. 31, 2017
Commitments and Contingencies (Textual)
Accrued expenses		$ 39,700		$ 39,700			$ 43,500
Purchase commitment of company		18,700		18,700
Performance bonds outstanding		15,100		15,100
Escrow deposit						$ 11,750
Cash and cash equivalents		10,000		10,000			$ 10,800
Payment for transfer of the IP Interest	$ 6,000			6,000
Payment for settlement of claims and mutual release	$ 10,000
Stockholders, ownership percentage	22.00%
Net proceeds from sale of majority interests in New SPIP	$ 6,000			6,000
Company paid Straight Path an aggregate of cash	$ 16,000
Legal fees		846	$ 889	1,625	1,088
Straight Path Class Action [Member]
Commitments and Contingencies (Textual)
Legal fees		$ 200,000	$ 0	$ 1,000,000	$ 0

XML

Other Income (Expense), Net (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2018	Jan. 31, 2017	Jan. 31, 2018	Jan. 31, 2017
Schedule of other (expense) income, net
Foreign currency transaction (losses) gains	$ 169	$ (729)	$ (559)	$ 1,330
Gain on sale of marketable securities	(16)	305	(9)	305
Gain on investments	179	32	59	295
Other	38	(27)	53	44
Total other (expense) income, net	$ 370	$ (419)	$ (456)	$ 1,974

XML

Income Tax and New Jersey Corporation Business Tax (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
	Dec. 22, 2017	Jan. 31, 2018	Jan. 31, 2017	Jan. 31, 2018	Jan. 31, 2017	Sep. 30, 2017
Income Tax and New Jersey Corporation Business Tax (Textual)
Benefit from income taxes		$ (1,514)	$ 1,761	$ (99)	$ (12,655)
Tax credits to be received						$ 21,100
Tax credit, description				In September 2017, the Company, IDT Domestic Telecom, Inc. (a subsidiary of the Company) and certain other affiliates, were certified by the New Jersey Economic Development Authority as having met all of the requirements of the Grow New Jersey Assistance Act Tax Credit Program. The corporation business tax credits to be received are a maximum of $21.1 million. The Company may claim a tax credit each tax year for ten years beginning in 2017. The tax credit can be applied to 100% of the Company's New Jersey tax liability each year, and the unused amount of the annual credit can be carried forward. In addition, the Company may apply for a tax credit transfer certificate to sell unused tax credits to another business. The tax credits must be sold for no less than 75% of the value of the tax credits. The tax credits are subject to reduction, forfeiture and recapture if, among other things, the number of full-time employees declines below the program or statewide minimum.
Maximum [Member]
Income Tax and New Jersey Corporation Business Tax (Textual)
U.S. federal statutory corporate tax rate				35.00%
Minimum [Member]
Income Tax and New Jersey Corporation Business Tax (Textual)
U.S. federal statutory corporate tax rate				21.00%
Elmion Netherlands B.V. [Member]
Income Tax and New Jersey Corporation Business Tax (Textual)
Benefit from income taxes					$ 16,600
AMT [Member]
Income Tax and New Jersey Corporation Business Tax (Textual)
Noncurrent receivable		3,300		$ 3,300
Benefit from income taxes		$ 3,300
Tax Cuts and Jobs Act [Member]
Income Tax and New Jersey Corporation Business Tax (Textual)
U.S. federal statutory corporate tax rate	26.90%